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1. ABSTRACT
Mycoplasma agalactiae is the etiological agent of contagious agalactia, a serious 
disease of small ruminants characterized by mastitis, polyarthritis, keratoconjunctivitis, 
and abortion.
Mycoplasmas  totally  lack  the  cell  wall,  so  membrane  proteins  are  directly 
exposed to environment. To date, a limited number of M. agalactiae antigens have been 
described. The combination of 2-D PAGE and mass spectrometry is a well-established 
method for proteome studies; however, it is reported that standard 2-D PAGE lacks in 
resolution  of  hydrophobic  and  basic  proteins,  which  are  abundant  in  mycoplasmas 
membrane. Indeed, membrane proteins are poorly represented in total extracts maps.
In this study, the membrane proteome of M. agalactiae PG2T was characterized. 
The  Triton  X-114  fractionation  allowed  the  enrichment  for  M.  agalactiae PG2T 
membrane proteins. Liposoluble proteins were subjected to 2-D PAGE-MS, leading to 
the  identification  of  40  unique  proteins.  The  differential  expression  of  liposoluble 
proteins, among PG2T strain and two field isolates, was revealed by 2D DIGE.
The use of GeLCMS/MS allowed to increase the coverage of the liposoluble 
proteome. A total of 194 unique proteins were identified, (26% of M. agalactiae PG2T 
genes)  and  subjected  to  gene  ontology  analysis  for  localization  and  function. 
Interestingly,  the 11.5% of  identified  proteins  derived from putative  horizontal  gene 
transfer events.
This  work paves  the way for the development  of  diagnostic  and prophylaxis 
tools.
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2. INTRODUCTION
2.1 Mycoplasmas: taxonomy and main biological features
Mycoplasmas (from the Greek, müces: fungus; plasma: formed) are the smallest 
and  simplest  self-replicating  organisms  being  provided  only  with  the  minimal 
machinery required for survival (Carter and Chengappa, 1991); phenotypically, they are 
distinguished from other bacteria by their small size (0.2-0.8 μm) and total lack of cell 
wall (Fig. 1) (Razin et al., 1998).
Figure 1: Electron micrograph of thin-sectioned mycoplasma cells
The number of mycoplasmas is continuously increasing, and actually 180 species 
are known and classified in the phylum Tenericutes, class  Mollicutes  (from the Latin, 
mollis:  "soft";  cutis:  skin),  order  Mycoplasmatales,  family  Mycoplasmataceae,  genus 
Mycoplasma (Razin and Freundt, 1984; Razin, 1991, 1993). The introduction of 16S 
rRNA sequencing allowed to extend Mollicutes taxonomy. In fact, Haemobartonella and 
Eperythrozoon  genera,  historically  considered  more  closed  to  Rickettsiae,  are  now 
included  in  Mycoplasmataceae.  The  current  classification  of  Mollicutes and  the 
properties distinguishing the currently established taxa are presented in Table 1.
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Classification Current no. of recognized species
Genome size 
(kb)
Mol% G + C of 
genome
Cholesterol 
requirement Distinctive properties Habitat
Order I: Mycoplasmatales
Family I: Mycoplasmataceae
Genus I: Mycoplasma 102 580-1350 23-40 Yes Optimum growth at 37°C Humans, animals
Genus II: Ureaplasma 6 760-1170 27-30 Yes Urea hydrolysis Humans, animals
Order II: Entomoplasmatales
Family I: Entomoplasmataceae
Genus I: Entomoplasma 5 790-1140 27-29 Yes Optimum growth at 30°C Insects, plants
Genus II: Mesoplasma 12 870-1100 27-30 No Optimum growth at 37°C; 




Genus I: Spiroplasma 33 780-2220 24-31 Yes Helical motile filaments; 









Genus I: Anaeroplasma 4 1500-1600 29-34 Yes Oxygen-sensitive anaerobes Bovine/ovine rumen
Genus II: Asteroleplasma 1 1500 40 No Oxygen-sensitive anaerobes Bovine/ovine rumen
Undefined taxonomic status
Phytoplasma Not defined 640-1185 23-29 Not known Uncultured in vitro Insects, plants
Table 1: Major characteristics and taxonomy of the class Mollicutes (adapted from Razin et al., 1998)
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Because of the lack of cell wall, mycoplasmas show a great pleomorphism; the 
predominant shape is sphere, but many mollicutes exhibit  a variety of morphological 
entities,  including  pear-shaped  cells,  flask-shaped  cells  with  terminal  tip  structures, 
filaments of various lengths, and helical filaments. The ability to maintain such shapes 
in the absence of a rigid cell wall has long indicated the presence of a structure similar 
to cytoskeleton. Moreover, some of the flask-shaped Mycoplasma species are capable of 
gliding on solid surfaces (Razin et al., 1998). The cytoskeleton-like structure is thought 
to function in modulating cell shape and to participate in cell division, gliding motility, 
and the proper localization of adhesins (Razin et al., 1998).
Mycoplasmas  replicate  by  binary  fission,  but  often  division  is  not  fully 
synchronized  with genome replication,  and the cytoplasmic  division may lag behind 
genome replication, resulting in the formation of multinucleate filaments (Fig. 2).
Figure 2: Schematic presentation of mycoplasma reproduction
The transformation of mycoplasma filaments into chains of cocci followed by 
microcinematography revealed the appearance of constrictions in the cell membrane at 
about equal distances along the entire length of the filament (Razin, 1978).
Mycoplasmas regressively evolved from gram-positive bacteria by reduction of 
their genome to an essential minimum, economizing their structural elements, metabolic 
pathways,  and  genetic  resources  (Razin  et  al.,  1998).  The  mycoplasma  genome  is 
typically  prokaryotic,  consisting  of  a  circular,  double  stranded  DNA molecule.  The 
genome size ranges from 580 kb of  M. genitalium to 1380 kb of  M. mycoydes subsp. 
mycoydes LC. Size is variable not only within the same genus but even among strains of 
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the  same  species  (Citovsky  et  al.,  1988;  Robertson  et  al.,  1990;  Ladefoged  and 
Christiansen,  1992;  Huang  et  al.,  1995).  This  variability  can  be  explained  by  the 
occurrence of  repetitive  elements  or  insertion  sequences,  by the integration  into  the 
chromosome of viral sequences, and by horizontal  gene transfer (Razin  et al.,  1998; 
Sirand-Pugnet et al., 2007).
Mycoplasma genomes  are characterized  by a very low G+C content,  ranging 
from 24 to 33 mol% (Tully and Razin, 1996). This feature was probably determined by 
the low specific activity of mycoplasmas uracil-DNA glycosylase, functioning in the 
removal of uracil residues from DNA arising by spontaneous deamination of cytosine 
residues (Wieslander  et al., 1995). The decreased capacity of mycoplasmas to remove 
uracil residues from DNA would favor the gradual replacement of G · C base pairs with 
A · T base pairs, leading to the low G+C content of mollicutes genomes (Razin et al., 
1998). The G+C content along the chromosome is not equal. For instance, while  M. 
genitalium genome has an average G+C content of 32 mol%, the G+C content of its 
rRNA genes is 44 mol% and that of its tRNA genes is 52 mol% (Fraser et al., 1995). 
Moreover,  the  M.  pneumoniae adhesin  genes,  P1  and  ORF6,  and  their  repetitive 
sequences, exhibit a G+C content as high as 56 mol%, while on the other extreme the 
origin of replication of this mycoplasma has a G+C content of only 26 mol%, compared 
to 40 mol% of the entire  M. pneumoniae genome (Himmelreich  et al., 1996, 1997). 
Consequently, many of the mycoplasmal intergenic regions have a higher A+T content 
than do the coding regions, reaching values as high as 80 to 90 mol% (Muto and Osawa, 
1987; Yogev et al., 1991; Dybvig and Yu, 1994). The variable G+C content of coding 
regions within the mycoplasmal genome indicates the highly conserved nature of the 
rRNA and tRNA genes and the possible exogenous origin of the adhesin genes (Razin 
et al., 1998).
The  high  A+T  content  in  mycoplasma  genome established  an  evolutionary 
pressure that drove to the preferentially usage of A and T rich codons, and finally to 
proteins with low Gly, Pro, and Arg content. The A-T pressure led to the reassignment 
of UGA stop codon to a tryptophan one, as already seen in mitochondria (Osawa et al., 
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1992). As a consequence, the expression of mycoplasma recombinant proteins in E. coli 
is hampered, and it is necessary the modification of these codons (Razin et al., 1998).
It would be expected that the lack of the cell wall facilitate the introduction of 
exogenous DNA into mycoplasma cells, but it was demonstrated that the exchange of 
chromosomal  DNA  during  direct  contact  of  mycoplasma  cells  and  conjugative 
transposition of transposon Tn916 from  Streptococcus (Enterococcus)  faecalis, has a 
very  low  efficiency.  Moreover,  the  recent  work  by  Sirand-Pugnet  and  coworkers 
revealed the occurrence of horizontal gene transfer (HGT) events in M. agalactiae. The 
analysis  of  genomic  data  demonstrated  the  acquisition  of  entire  operons  by  M. 
agalactiae from M. capricolum subsp. capricolum and M: mycoydes subsp. mycoides; it 
is important to notice that these mycoplasma species belong to different phylogenetic 
cluster,  but  they share  the  same hosts,  so  the  genetic  exchange may occour  during 
coinfections (Sirand-Pugnet  et al., 2007). The mechanism of this exchange is already 
unclear, but it was hypothesized that it is mediated by a spontaneous mating process that 
probably involves transient fusion of the cell membranes at the zone of contact (Roberts 
and Kenny, 1987; Barroso and Labarère, 1988).
Under laboratory  conditions  increased  transformation  and  transfection 
efficiencies have been achieved either in the presence of polyethylene glycol (PEG) or 
by application of the electroporation procedure, and the application of these methods 
lead to important genetic and functional studies (Razin et al., 1998).
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2.2 Metabolism
During  their  evolution, mycoplasmas  saved  only few  genes  for  biosynthetic 
pathways, and it can be speculated the these are the really essential for a minimal cell 
survival. Mycoplasmas have lost all the genes for amino acid and cofactors biosynthesis; 
as a result,  mycoplasmas depend on host resources for living and evolved a parasitic 
lifestyle  (Razin  et  al.,  1998).  Moreover,  because  of  the  lack  of  the  cell  wall, 
mycoplasmas are more sensitive to osmotic shock than other bacteria, and the parasitic 
mode indirectly protect them because the host provide a constant osmotic environment 
(Razin et al., 1998).
The  reductive  evolution  also  affected  the  lipid  metabolism.  In  fact,  most 
mycoplasmas depend on host  supply for  fatty acids,  because they cannot  synthesize 
them.  Moreover,  although  mycoplasmas  are  usually  able  to  synthesize  their  own 
membrane phospholipids  and glycolipids  from the exogenously provided fatty acids, 
some mycoplasmas incorporate preformed host phospholipids into their membrane. This 
way,  it  is  not  possible  to  regulate  the  membrane  fluidity  with  selective  fatty  acid 
synthesis;  mycoplasmas  control  membrane  fluidity  incorporating  large  amounts  of 
exogenous cholesterol in their membrane (Razin, 1978).
Mycoplasmas preserved the salvage pathways using purines and pyrimidines for 
the synthesis of ribonucleotides and their conversion to deoxyribonucleotides; despite 
that,  mycoplasmas  generally  use  preformed  exogenous  nucleotides  that  they  get 
degrading host DNA and RNA with their potent nucleases (Razin, 1978; Minion et al., 
1993; Bendjennat et al., 1997, 1999; Paddenberg et al., 1998; Hopfe et al., 2008).
The analysis of the sequenced mycoplasma genomes revealed that the number of 
genes involved in  DNA replication and repair,  in transcription,  and in translation is 
smaller than in other bacteria; thus, it can be speculated that mycoplasmas possess the 
minimal machinery for protein synthesis. The rate of protein synthesis, and consequently 
of cell replication, is very low. This represents an advantage for a parasite that would 
lose its safe environment by killing its host; in fact, mycoplasmosis are usually mild and 
chronic infections (Razin et al., 1998).
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The reductive evolution involved also many other cellular processes, such as the 
cell division, the heat shock response, and the proteins secretion system. For instance, 
the number of the protein secretion  complex is  smaller  than in  E. coli;  the simpler 
secretion  machinery could  be  a  consequence  of  the  simplicity  of  mycoplasma  cell. 
Moreover,  because  of  the  lack  of  the  periplasmic  space,  in  mycoplasmas  protein 
refolding must be linked to cell surface; they solved this problem anchoring proteins to 
membrane by long acyl chains (lipoproteins) (Razin et al., 1998).
Despite the importance of nutrients uptake from the host, mycoplasmas do not 
have many genes for membrane transport.  The scarcity of the number of this kind of 
genes can be explained by the presence of only one barrier between mycoplasmas and 
the host cells.  Another explanation is  the apparent low substrate specificity of some 
mycoplasmal  transport  systems,  such as  those  for  amino  acids  (Himmelreich  et  al., 
1997).  Three  types  of  transport  systems  were  found  in  M.  genitalium and  M. 
pneumoniae (Fraser et al., 1995; Himmelreich et al., 1996). The first is ABC transporter 
systems, consisting of two ATP binding domains,  two membrane spanning- and one 
substrate-binding domain; frequently present on separate polypeptides. The second type 
consists  of  PTS systems for  transporting sugars,  resembling homologous systems of 
gram-positive  bacteria.  The  third  is  facilitated  diffusion  by transmembrane  proteins 
functioning as specific carriers.
The reducing process  of  mycoplasmas  evolution  involved  also the  metabolic 
activities  for  energy generation.  All  the  mollicutes  examined  so  far  have  truncated 
respiratory systems; they lack a complete tricarboxylic acid cycle and have no quinones 
and  cytochromes,  ruling  out  oxidative  phosphorylation  as  an  ATP-generating 
mechanism (Razin, 1978; Miles, 1992; Pollack et al., 1997). On the basis of their ability 
to  metabolize  carbohydrates,  the  mollicutes  are  divided  into  fermentative  and  non-
fermentative  organisms;  the  fermentative  mycoplasmas  produce  acids  from 
carbohydrate metabolism, decreasing the pH of the medium (Razin et al., 1998). Most 
of the non-fermentative mollicutes and some fermentative species possess the arginine 
dihydrolase pathway, that leads to the production of ornithine, ATP, CO2, and ammonia, 
raising the pH of the culture medium (Razin,  1978).  The degradation of arginine is 
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coupled  to  equimolar  generation  of  ATP  by  substrate-level  phosphorylation.  Some 
mycoplasmas, such as  M. agalactiae,  M. bovigenitalium, and M. bovis do not use this 
two metabolic  pathways  but  are  able  to  oxidate  organic  acids  (lactate,  pyruvate)  to 
acetate and CO2 (Miles, 1992; Taylor  et al.,  1994; Tully and Razin,  1996). Another 
mollicutes mechanism for energy production is based on ATP generation from acetyl 
phosphate and ADP by acetate kinase, coupled with acetyl phosphate formation from 
acetyl-CoA  by phosphate  acetyl  transferase;  both  enzymes  are  commonly  found  in 
fermentative  and  non-fermentative  mollicutes.  Acetyl-CoA  can  be  produced  by 
oxidative phosphorylation of pyruvate by mycoplasmas (Razin, 1978).
2.3 In vitro cultivation
The  fastidious  nature  of  mycoplasmas  hampered  the  research  and laboratory 
diagnosis of mycoplasmosis. Only a minority of existing species has been cultivated in  
vitro and many mycoplasmas grow very slowly on available media (Razin, 1994). The 
difficulty of  cultivation  are  explained  by scarcity of  genes  involved  in  biosynthetic 
pathways, such as that for amino acid synthesis (Fraser et al., 1995; Himmlreich et al., 
1997). As a consequence, mycoplasmas evolved a parasitic lifestyle, and they are totally 
dependent  on  the  exogenous  supply for  many substances,  that  must  be  provided  in 
complex media, based on beef heart infusion, peptone, yeast extract, and serum with 
various supplements (Razin, 1991). Serum is very important in mycoplasmas cultivation 
because it  provides,  among other  nutrients,  fatty acids  and cholesterol  (required  for 
membrane  synthesis)  in  an  assimilable  non-toxic  form.  The  lipid  requirements, 
particularly for cholesterol, were used as taxonomic criterion distinguishing the sterol-
nonrequiring  mollicutes,  particularly  the  Acholeplasma species,  from  the  sterol-
requiring ones (Table 1).
Some  Mollicutes grow under  laboratory conditions  only when  co-cultivatied 
with  eukaryotic  cell  lines;  in  many cases,  after  co-cultivation,  mycoplasmas  can  be 
subcultured in cell-free systems (Jensen et al., 1994, 1996).
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One of the most useful distinguishing features of mycoplasmas is their peculiar 
fried-egg colony shape,  when cultured in solid media, consisting of a central zone of 
growth embedded in the agar and a peripheral one on the agar surface (Fig. 3) (Rottem 
and Kahane, 1993).
Figure 3: Morphology of a typical "fried-egg" mycoplasma colony. A: schematic representation;
B: Mycoplasma agalactiae colonies on solid medium
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2.4 Mycoplasma lipoproteins
Mycoplasma membrane has a very high protein content, representing over one 
third of  membrane mass  and about  50% of total  proteins  of  the cell.  Among them, 
lipoproteins  are considered the most  interesting class since their  abundance is  much 
higher  than  in  eubacteria.  Mycoplasma lipoproteins  genes  code for  a  signal  peptide 
upstream a cysteine residue (Himmelreich et al., 1996); this residue is modified in the 
sulfhydryl group by the transfer of a diacylglycerol moiety from glycerophospholipid; 
the signal peptidase II turns the prolipoprotein into the mature form cleaving the signal 
peptide,  so  the  modified  cysteine  becomes  the  first  amino  acid.  Mycoplasma 
lipoproteins can be di- or tri-acylated, but the transacylase responsible for the acylation 
of the amino group of cysteine was never identified (Razin et al., 1998).
Mycoplasmas posses a very high phenotypic plasticity;  in fact, lipoproteins, the 
most immunodominant mycoplasmal antigens, often undergo size and/or phase variation 
(Fig. 4) (Glew et al., 2000; Chopra-Dewasthaly et al., 2008).
Figure 4: Colony blotting of M. bovis PG45T revels differential expression of variable surface 
lipoproteins
This feature allows mycoplasmas to evade host immunity by constantly changing 
their antigenic mosaic, and to enhance the colonization of host tissues (Dramsi  et al., 
1993; Rainey et al., 1993). The major survival strategy of the mycoplasmas seems to 
depend  on  random  and  stochastic  processes,  consisting  of  various  mutational 
mechanisms which generate high-frequency phenotypic switching (Razin  et al., 1998). 
There are two main strategies to accomplish surface protein variation. The first is based 
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on  the  variation  of  the  number  of  repeated  sequences,  by  both  homologous 
recombination and slipped-strand mispairing (Levinson and Gutman, 1997; Rasmussen 
et al., 1992; Robertson et al., 1992); this mechanism leads to the size variation of the 
antigen The second mechanism is the site-specific inversion of the promoter upstream 
the  coding  sequence,  that  switches  ON/OFF  the  expression  of  the  protein;  this 
hypothesis is validated by the presence of  a site-specific tyrosine recombinase gene 
nearly the genes coding for variable surface lipoproteins (Flitman-Tene et al., 2003).
2.5 Invasivity and pathogenicity
Mycoplasmas are widespread in nature as parasites and commensals of humans, 
mammals, reptiles, fish, arthropods, and plants. Usually mycoplasmas show a strict host 
and  tissue  specificity,  probably  reflecting  their  nutritional  requirements  and  their 
parasitic  lifestyle,  but  there  are  many reports  of  the  their  presence  outside  of  their 
normal  habitats  (Razin,  1992;  Razin  et  al.,  1998).  Human and animal  mycoplasmas 
colonize  preferentially  the  respiratory  and  urogenital  tracts,  eyes,  alimentary  canal, 
mammary glands, and joints; the obligatory anaerobic anaeroplasmas have been found 
in bovine and ovine rumen only (see Table 1).
The adhesion of mycoplasma to host cell is essential for colonization and for 
infection; adhesion-deficient mutants exhibit loss of infectivity and the revertion to wild 
type is coupled with the gain of infectivity and virulence (Razin et al., 2008). It has been 
proposed that during contact of mycoplasmas with the host cell membrane there could 
be a local, perhaps transient fusion of the two membranes. Moreover, there could take 
place exchange of  membrane components  and direct  “injection”  of  the  mycoplasma 
cytoplasmic content, such as hydrolytic enzymes, into the host cell cytoplasm (Razin et  
al., 1998). Mycoplasma adhesion to host cells could be mediated by specific structures 
or proteins called adhesin, that interact with host surface proteins, such as receptors. It is 
interesting to notice that  many mycoplasma surface proteins undergo size and phase 
variations; by this mechanism mycoplasmas evade host immune response and, at the 
same time, and increase the chances to find the right receptors on different tissues of the 
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host and adapt to the different niches (Razin  et al.,  1998). Moreover, a recent work 
highlighted  the  role  of  elongation  factor  tu,  a  protein  with  tipically  cytoplasmatic 
localization,  in  adhesion,  by its  interaction  with fibronectin (Balasubramanian  et al., 
2008).
Mycoplasmas  usually locate  on  the  surface  of  host  cells,  but  it  was  already 
demonstrated that polymorphonuclear leukocytes and macrophages are able to take up 
human and animal mycoplasmas (Marshall  et al., 1995, 1998). The mechanism of cell 
entry is  still  unclear.  Mycoplasmas such as  M. fermentans and  M. hominis,  have no 
dedicated structures (Wise, 1993), while other mycoplasmas with intracellular location, 
such  as  M.  penetrans and  M.  genitalium appear  to  enter  host  cells  through  their 
specialized tip structure (Fig. 5) (Lo et al., 1993; Jensen et al., 1994).
Figure 5: Mycoplasma hominis adhesion structures
Following contact of  M. genitalium with human lung fibroblasts, the host cell 
membrane appeared to be forced to form a cup or a depression. The membrane pockets 
resembled clathrin-coated pits,  suggesting that  the mycoplasma might  adhere to  and 
enter the cells  by a site-directed,  receptor-mediated event,  similar  to the chlamydias 
mechanism (Mernaugh et al., 1993; Razin et al., 1998). The presence of mycoplasmas, 
some of which may not even be enclosed within a vacuole, inside the host cells may 
expose  the  cytoplasm and the  nucleus  to  mycoplasmal  hydrolytic  enzymes,  such as 
proteases, nucleases, and phospholipases. For instance, the potent endonuclease of  M. 
penetrans was  suggested  to  cause  chromosomal  damage  and  to  promote  apoptosis 
(Bendjennat et al., 1997, 1999; Paddenberg et al., 1998; Hopfe et al., 2008).
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Moreover,  intracellular  location,  if  even  for  a  short  period,  may protect  the 
mycoplasmas from the host immune system and antibiotics and may account to some 
extent for the difficulty of eradicating mycoplasmas from infected cell cultures. Thus, 
intracellular residence promotes the establishment of latent or chronic infection states 
and  circumvents  bactericidal  immune  mechanisms  and  selective  drug  therapies 
(Baseman and Tully, 1997).
Toxins were never identified in mycoplasmas and in general their pathogenetic 
mechanisms are still  to  be fully clarified.  It is  known that  mycoplasmas can induce 
oxidative stress in the host because of their  metabolism products,  such as hydrogen 
peroxide and superoxide radicals (Fig 6) (Razin et al., 1998).
Figure 6: Proposed mechanism of oxidative damage to host cells by adhering M pneumoniae by 
increasing concentrations of H2O2 and O2-.
It was reported that M. orale can deregulate and reduce the number of Cl- and of 
Ca2+-activated K+ channels of human submandibular gland cell line; these changes  in  
vivo  could  lead  to  a  diminished  fluid  production  and,  consequently,  to  xerostomia 
(Izutsu et al., 1996; Razin et al., 1998). Similarly, in mycoplasma-infected ciliary cells, 
such as ciliated bronchial epithelia, it was reported the ciliostasis; the preferential loss of 
K+ channels and the consequent depolarization of the membrane, could lead to a similar 
situation (DeBey and Ross, 1994; Izutsu et al., 1996; Razin et al., 1998).
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2.6 Diagnosis of mycoplasmosis
Mycoplasmosis diagnosis is hampered by the great number of variable clinical 
signs that make necessary the use of laboratory tools.
The  classical  diagnostic  technique  used  for  dectecting  and  characterizing 
mycoplamas  was  their  isolation  in  vitro from  swabs,  milk  or  other  fluids.  The 
identification with this method can be very difficult because of their fastidious nature. 
Mycoplasma  colonies  appear  typically  after  about  72-96  h,  and  after  5-7  days  the 
characteristic  spots  and  films  can  be  appreciated,  a  thin  layer  of  lipids  and 
carbohydrates.
The biochemical identification allows mycoplasma classification on the basis of 
the  metabolism  of  some  molecules,  such  as  pyruvate,  glucose,  arginine;  the  major 
disadvantage of these methods is that they are time consuming.
The  immunofluorescence  and  immunohistochemistry  are  useful  to  avoid 
contaminations, but the procedures are very long and expensive (Adegboye et al., 1995) 
and depends on the availability of specific and sensitive sera.
In the past, many other thecniques were proposed for mycoplasmas diagnosis, 
but their  application was limited by their  time-consuming nature, their  high costs or 
their low specificity, such as dot immunoblot, western blotting, complement fixation, 
DNA hybridation,  indirect  hemagglutination,  and radial  hemolysis  (Poumarat  et  al., 
1992; Dohms et al., 1993).
Actually, the most used diagnostic tests are ELISA and PCR. ELISA tests allows 
to reveale both antigens or antibodies, and it is a very simple, fast, and cheap method 
(Rosati  et al., 1999, 2000; Robino et al., 2005; Alberti  et al., 2008). PCR is the most 
sensitive and specific diagnostic tool; it allows the direct identification of the pathogen, 
and it could be performed after in vitro culture or directly on swabs, milk or other fluids 
(Tola et al., 1996; Alberti et al., 2006).
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2.7 Mycoplasma agalactiae and Contagious Agalactia
Mycoplasma agalactiae is the aetiological agent of Contagious agalactia (CA), 
an economically detrimental disease of small ruminants. CA is characterized by mastitis, 
polyarthritis and keratoconjunctivitis; in lambs, losses due to septicemia and pneumonia 
can be high. Some outbreaks may affect most of the animals on a farm. Actually, CA 
was reported in 31 countries, and the only continent CA-free is Oceania (Corrales et al., 
2007). CA is endemic in the Mediterrean area, Africa, and Asia; in America, exept for 
the USA, this disease is described as sporadic (Bergonier  et al., 1997; Corrales  et al., 
2007).
The control of this disease is very difficult because of the intrinsic characteristics 
of mycoplasmas. Antibiotic therapy can result in symptomatic improvement, but treated 
animals may remain carriers due to antibiotic resitence.
Infected animals shed organisms in urine, feces, nasal and ocular discharges, and 
secretions including milk.  Mycoplasmas can be shed during more than one lactation; 
between  lactations,  the  organisms  can  survive  in  the  supramammary  lymph  nodes. 
Carrier animals can remain infectious for months, and in some cases, for more than a 
year. Animals become infected by ingestion or occasionally by inhalation, as well as 
through  the  teat  openings.  Young  animals  are  usually  infected  when  they  drink 
contaminated milk or colostrum from the dam. In rare cases, animals can also ingest 
mycoplasmas shed in other secretions and excretions, either directly or in feed or water. 
Organisms can enter the teat opening directly during milking, or from fomites such as 
bedding. Aerosol transmission is possible over short distances, but rare.
Mycoplasma agalactiae  survive in the environment thanks to its  biofilm, that 
prevent the death for heat or drying.
Generally,  the  clinical  signs  are  more  severe  in  goats.  Infections  with  M. 
agalactiae may be asymptomatic, acute or chronic. Acute cases begin with a transient 
fever followed by malaise, inappetence and mastitis. The udder is hot and swollen, and 
the milk is usually greenish–yellow or grayish–blue, with a consistency that is watery at 
first then becomes lumpy. Lactation diminishes and may completely stop. Eventually, 
the udder atrophies and becomes fibrosed. Polyarthritis is also common, especially in 
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the tarsal and carpal joints, and may be the major clinical sign in male goats; the severity 
of this  synthom can vary.  Keratoconjunctivitis  develops in approximately half  of all 
infections.  It  is  usually  transient,  but  occasionally becomes  chronic,  and  can  cause 
blindness in one or both eyes (Fig. 7).
Figure 7: Clinical signs of CA. A: mastitis, B: Arthritis, C: Keratoconjunctivitis
Pneumonia  is  not  consistently  seen  with  M.  agalactiae,  but  organisms  are 
occasionally isolated  from lesions  in  the  lungs.  Abortions  can  occur  in  chronically 
infected animals. Granular vulvovaginitis has also been reported in goats (Farina and 
Scatozza, 1998).
In  areas  that  are  free  of  contagious  agalactia,  infected herds  are  usually 
quarantined and euthanized.  The premises  should  be cleaned and disinfected  before 
restocking. Mycoplasmas can be inactivated by many disinfectants including sodium 
hypochlorite (30 ml of household bleach in 1 gallon of water), 2% sodium hydroxide 
(pH 12.4), 1% formalin,  cresol, sodium carbonate (4% anhydrous or 10% crystalline 
with  1%  detergent),  and  ionic  and  nonionic  detergents.  Eradication  has  been 
accomplished in some areas by the euthanasia of infected and exposed flocks or herds.
In endemic areas, good management and hygiene can reduce the transmission of 
contagious  agalactia  in  a  herd.  The premises  and equipment  should  be cleaned and 
disinfected regularly, and sick animals should be isolated. Milking animals should also 
be separated from young animals. Removal of the newborn from the dam, with feeding 
of pasteurized colostrum and milk, can be helpful. Regular testing of the flock or herd, 
with culling or isolation of infected animals, can also help prevent disease introduction 
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and/or reduce its spread. ELISAs, culture and other tests have been useful in screening 
programs.
Antibiotics  can  result  in  symptomatic  improvement,  but  they  may  not  be 
effective in chronic joint infections or keratoconjunctivitis. Treatment may not eliminate 
the infection  from carriers.  Vaccines  may be available  for  some organisms in some 
areas. Inactivated vaccines generally provide short-term protection. Live vaccines can 
prevent symptoms, but do not prevent animals from becoming infected or shedding the 
organism. Vaccine organisms may also be shed in milk.
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3. RESEARCH OBJECTIVES
Mycoplasmas  are  the  smallest  and  simplest  prokaryotes  capable  of  self-
replication,  being  provided  only  with  the  minimal  machinery  required  for  survival 
(Razin  et  al.,  1998).  During  evolution,  they have  regressively  evolved  from  gram-
positive bacteria by reduction of their genome to an essential minimum, economizing 
their  structural  elements,  metabolic  pathways,  and  genetic  resources.  Among  other 
consequences,  this  cost-cutting  strategy led  to  loss  of  the  cell-wall  component,  and 
therefore  to  the  lack  of  a  peptidoglycan  “shell”. Integral  and  associated  membrane 
proteins  are  therefore  directly exposed at  the cell  surface  and act  as  the  immediate 
bacterial  interface, playing a major role in survival and pathogenesis (Rottem, 2003; 
You  et al.,  2006).  Gathering information on membrane proteins of such a pathogen 
might  provide  novel  and  interesting  insights  on  its  biology,  and  generate  useful 
information for improving diagnosis, vaccination, and therapy.
Many mycoplasmas are pathogenic for humans, animals, plants, and insects. M. 
agalactiae is the etiological agent of Contagious Agalactia (CA), a serious disease of 
sheep  and  goats  characterized  by  mastitis,  polyarthritis,  keratoconjunctivitis,  and 
abortion  (Lambert,  1987;  Razin  et  al.,  1998;  Corrales  et  al.,  2007).  In Europe,  the 
disease has been tentatively controlled either by vaccination or with serological tools 
based on recombinant surface proteins (Tola et al., 1999; Rosati et al., 2000; Greco et  
al., 2002; Nicholas, 2005; Fusco et al., 2007; Chessa et al., 2009). At present, the two 
above  mentioned  strategies  are  not  actually  compatible  until  proper  DIVA 
(Differentiating Infected from Vaccinated Animals) vaccines will allow discrimination 
of vaccinated animals from naturally infected ones.
The highly immunogenic, surface-associated membrane proteins represent key 
antigens for diagnosis  and vaccine development.  However,  the finding of constantly 
expressed  surface  proteins  in  mycoplasmas  is  complicated  by  the  existence  of 
mechanisms aimed to evade the host immune response (Razin et al., 1998; Glew et al., 
2000;  Chopra-Dewasthaly  et  al.,  2008).  To  date,  a  limited  number  of  constantly 
expressed surface proteins have been described in  M. agalactiae. Among them, P30, 
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P48, and P80 were described as antigens (Rosati et al., 1999; Fleury et al., 2001: Tola et  
al.,  2001);  other  proteins  belong  to  the  variable  surface  membrane  proteins  family 
(Vpma) (Glew et al., 2000; Chopra-Dewasthaly et al., 2008) and P40 was suggested to 
play an important role in attachment to the host cell (Fleury et al., 2002).
In 2007, the full genome sequence of the M. agalactiae PG2T was published and 
paved the way for systematic proteomic studies in mycoplasmas (Sirand-Pugnet  et al., 
2007).  The  combination  of  2-D  PAGE  and  mass  spectrometry  (MS)  is  a  well-
established  method  for  the  systematic  and comparative  study of  proteomes,  since it 
allows the simultaneous visualization and identification of the protein complement of a 
cell. However, it is commonly reported that standard 2-D PAGE lacks in resolution of 
very hydrophobic and basic proteins, which are particularly abundant in the mycoplasma 
membrane (Razin et al., 1998; Regula et al., 2000; Sirand-Pugnet et al., 2007). Indeed, 
membrane proteins are poorly detected in 2-D PAGE maps of mycoplasma total protein 
extracts  (Jores  et  al.,  2009).  Triton  X-114  fractionation  may assist  in  solving  this 
problem, since it  was demonstrated to enable a selective enrichment  in hydrophobic 
proteins (Bordier, 1981; Pittau et al., 1990). Triton X-114 fractionation followed by 2-D 
PAGE remains the method of choice for proteomic characterization of the membrane 
protein  subset  and  for  differential  analysis  of  membrane  protein  expression  among 
bacterial  strains  (Donoghue  et  al.,  2008;  Li  et  al.,  2009).  However,  considering the 
above  mentioned  intrinsic  limitations  of  2-D  PAGE,  other  gel-based  proteomic 
approaches, such as one-dimensional PAGE and Liquid Chromatography-Tandem Mass 
Spectrometry (GeLCMS/MS). can be combined with the 2-D PAGE/MS in order to 
mine deeper into a liposoluble proteome.
The  major  objective  of  this  work  is  the  characterization  of  M.  agalactiae 
membrane proteome, by means of Triton X-114 fractionation, 2-D PAGE-MS, GeLC-
MS/MS,  and  Gene  Ontology  classification.  Differential  expression  of  membrane 
proteins among M. agalactiae strains isalso evaluated by 2D DIGE. The results of this 
work will allow to develop new diagnostic and prophylaxis for the control of CA.
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4. MATERIALS AND METHODS
4.1 Media and buffers
PPLO medium
PPLO broth 21 g/L
Triptone 10 g/L
Yeast extract 5 g/L
Horse serum 20% v/v
H2OMQ to volume
Mycoplasma solid medium
Blood agar base 40 g/L
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β- mercaptoethanol 5% v/v
Tris-HCl pH 6.8 0.0625 M
Bromophenol blue 0.002% w/v
H2OMQ to volume
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4.2 Bacterial strains and culture conditions
At  least  three  replicate  cultures  of  Mycoplasma  agalactiae PG2T and  two 
Sardinian  field  isolates  (named  Bortigali  and Nurri),  were  grown in  PPLO medium 
supplemented  with  20% heat-inactivated  horse serum and 500 μg/mL ampicillin,  at 
37°C with constant agitation. Mycoplasmas were collected by centrifugation (10 min at 
10,000  x  g  at  4°C),  and  washed  three  times  with  ice-cold  PBS.  At  least  three 
mycoplasma pellets were obtained from each bacterial culture replicate, and used for 
genetic and proteomic analyses.
4.3 Total DNA extraction and PCR
Total DNA was extracted from a set of pellets with DNeasy Blood & Tissue Kit 
(Qiagen), and subjected to FS1-FS2 PCR for species confirmation (Tola et al., 1996).
FS1  5’-AAAGGTGCTTGAGAAATGGC-3’
FS2  5’-GTTGCAGAAGAAAGTCCAATCA-3’
The PCR reaction was conducted in a final volume of 50 μL using GoTaq DNA 
polymerase (Promega), in an Eppendorf Mastercycler® with the following amplification 
program:
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The PCR product  of  375 bp was  displayed on 2% agarose  gel  stained  with 
ethidium bromide.
4.4 Total proteins extraction
For total  protein extracts,  bacterial  pellets  were resuspended in 1% hot SDS, 
incubated for 3 minutes at 95°C, chilled,  and diluted with lysis buffer supplemented 
with 1% IPG-buffer  (GE Healthcare)  and protease inhibitors  (Sigma),  and insoluble 
materials  were  discarded  by centrifugation  (10  min  at  10,000  x  g  at  4°C)  (Ferrer-
Navarro et al., 2006).
4.5 Triton X-114 fractionation
Hydrophilic and hydrophobic protein fractions were obtained by Triton X-114 
fractionation (Bordier, 1981; Pittau et al., 1990), using the following protocol:
1. resuspend bacterial pellet with 900 μL of ice-cold PBS
2. add 100 μL of 10% Triton X-114
3. incubate for 5 minutes at 95°C
4. incubate for 1 h at 4°C under constant agitation
5. spin at 10,000 x g for 10 minutes at 4°C
6. transfer the supernatant into a new tube and incubate for 5 minutes at 37°C (since the 
solution achieves the cloud point)
7. spin at 8,000 x g for 3 minutes at room temperature
8. separate the two phases
8a  Lower phase (detergent): it carries 
hydrophobic proteins
8b.  Supernatant  (PBS):  it  carries 
hydrophilic proteins
9a add 900 μL of ice-cold PBS 9b add 100 μL of 10% Triton X-114
10a chill the tube on ice for 5 minutes 10b chill the tube on ice for 5 minutes
11a incubate at 37°C for 5 minutes 11b incubate at 37°C for 5 minutes
12a spin  at  8,000 x  g for  3  minutes  at 
room temperature
12b spin at  8,000 x g for 3 minutes  at 
room temperature
13a discard the supernatant 13b transfer the supernatant  into  a new 
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tube
14a repeat the wash step 3 times 14b repeat the wash step 3 times
15a  after  the  third  step,  discard  the 
supernatant  and  recover  the  detergent 
phase
15b  after  the  third  step,  transfer  the 
supernatant into a new tube and discard 
the detergent phase
Protein concentration was measured with RC DC Protein Assay kit (Bio-Rad) as 
already described (Ferrer-Navarro et al., 2006).
4.6 SDS-PAGE
Total extracts and hydrophobic and hydrophilic fractions of M. agalactiae PG2T 
proteins were diluted in loading buffer (Laemmli, 1970) and SDS-PAGE was performed 
on  8%  polyacrylamide  gels  on  a  Protean  Tetra  Cell  (Bio-Rad)  following  the 
manufacturer instructions. After run, gels were alternatively stained with PageBlue™ 
Protein Staining Solution (Fermentas), or subjected to Western immunoblotting.
4.7 Western immunoblotting
SDS-PAGE  resolved proteins  were transferred onto nitrocellulose membranes 
with a Mini-Trans-Blot Cell (Bio-Rad) at 250 mA for one hour at 4°C After blotting, 
membranes were blocked with PBS-T containing 3% BSA. Membranes were incubated 
for one hour with a rabbit hyperimmune serum raised against M. agalactiae recombinant 
P48 (M. agalactiae rP48) (Rosati  et al., 2000) diluted 1:1000 with blocking solution. 
Membranes were washed five times with PBS-T and incubated with the α-rabbit-IgG 
HRP-conjugated secondary antibodies (Sigma) diluted 1:250,000 in blocking solution. 
After  five  washes,  membranes  were  developed  with  Chemiluminescent  Peroxidase 
Substrate (Sigma) and images were acquired with a VersaDoc MP 4000 Imaging System 
(Bio-Rad).
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4.8 2-D PAGE
Prior to 2-D PAGE, Triton X-114 fractions  were precipitated with methanol-
chloroform (Wessel and Flügge, 1984) with the following protocol:
1. add to sample 4 volumes of methanol and vortex
2. add 1 volume of chloroform and vortex
3. add 3 volumes of H2OMQ and vortex
4. spin 1 minute at 14,000 x g
5. discard top acqueous phase (proteins are between layers)
6. add 4 volumes of methanol and vortex
7. spin 2 minutes at 14,000 x g
8. discard methanol
9. dry in SpeedVac®
After  precipitation  protein  samples  were resuspended  in  lysis  buffer 
supplemented  with 1% IPG-buffer  (GE Healthcare)  and protease inhibitors  (Sigma). 
Resuspended proteins (150 µg) were then absorbed overnight into 18 cm IPG strips (GE 
Healthcare, pH 3-10 NL, pH 7-11, and pH 4-7). Strips were focused on an IPGphor (GE 
Healthcare) for a total of 60,000 Vh with the following program:
No. step Volt Gradient Time
1 250 V Linear 2h
2 500 V Linear 2h
3 750 V Linear 2h
4 1000 V Linear 2h
5 5000 V Linear 2h
6 9000 V Linear 2h
7 9000-60000 V/h Step’n’hold
8 200 V Linear ∞
After  focusing,  strips  were  equilibrated  in  equilibrating  buffer  supplemented 
with 2% DTT for 15 min, and then with 2.5% iodoacetamide for 15 min. The second 
dimension (SDS-PAGE) was conducted on 10% to 18% polyacrylamide gradient gels, 
on an Ettan DALTsix electrophoresis system (GE Healthcare), following manufacturer’s 
instructions.  After run, 2-D gels were silver stained with a mass-compatible  method 
(Chevallet et al., 2006):
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1. fix the gel for 30 minutes with 50% methanol,10% acetic acid
2. wash for 15 minutes with 5% methanol
3. wash 3 times with H2OMQ for 15 minutes
4. sensitivization: 15 minutes with 120 mg/L sodium thiosulfate
5. wash 3 times with H2OMQ for 30 seconds
6. incubate with 2 g/L silver nitrate for 25 minutes
7. wash 3 times with H2OMQ for 30 seconds
8. develop  with  30  g/L  sodium  carbonate,  supplemented  with  2.4  mg/L  sodium 
thiosulfate, and 500 μl/L 37% formaldehyde
9. stop: 14 g/L EDTA, pH 8
All images were digitalized with an Image Scanner (GE Healthcare).
4.9 2D DIGE
For 2D DIGE analysis, the two field isolates Bortigali and Nurri were compared 
to PG2T. Triton X-114 Protein extracts were precipitated and resuspended in lysis buffer 
as  described  above.  Then,  samples  were  labeled  with  CyDye  DIGE  Fluors  (GE 
Healthcare) according to the minimal labeling protocol provided by the manufacturer. 
Briefly, after CyDye reconstitution with dimethylformamide (DMF) and preparation of a 
working solution (200 pmol/µL), 1 µL of diluted CyDye was added to a volume of 
protein sample equivalent to 50 µg. Samples were left on ice for 30 minutes in the dark, 
and then 1 µL of 10 mM lysine was added to stop the reaction. Labeled samples were 
mixed,  IPG buffer  corresponding to  the  desired pH range was added at  a  1% final 
concentration, and DeStreak Rehydration Solution (GE Healthcare) was added to a total 
volume of 340 µL. 18 cm IPG strips (GE Healthcare) were passively rehydrated for at 
least 6 hours. IEF was carried out on an Ettan IPGphor II (GE Healthcare) for a total of 
~60,000 Vh, as described above. After focusing, strips were equilibrated in equilibrating 
buffer supplemented with 2% DTT for 10 min, and then with 2.5% iodoacetamide for 
10 min. Proteins were then subjected to SDS-PAGE in 10-18% gradient polyacrylamide 
gels  on  the  Ettan  DALTsix  system  (GE  Healthcare),  following  the  manufacturer 
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instructions. DIGE images were detected with a Typhoon Scanner (GE Healthcare) and 
processed with DeCyder (GE Healthcare) for image analysis.
4.10 Spot picking and in situ tryptic digestion
Protein spots obtained upon 2-D PAGE separation of the Triton X-114 extract 
from  the  strain  PG2T were  manually  excised  from  gels,  destained  with  15  mM 
K3Fe(CN)6 in 50 mM Na2S2O3 and stored in acetonitrile. Spots were then subjected to an 
O/N tryptic digestion at 37°C in 50 mM (NH4)HCO3,  pH 8.0, using 40 to 80 ng of 
trypsin depending on spot intensity.  Peptide mixtures were collected by elution with 
acetonitrile  followed by centrifugation.  Peptides were then acidified with TFA 20%, 
dried in SpeedVac®, resuspended in 0.2% formic acid and stored at -20°C.
4.11 GeLC-MS/MS.
The  Triton  X-114  fraction  was  diluted  with  4X  Laemmli  buffer  (Laemmli, 
1970), 20 μg of proteins were loaded in an 8% polyacrylamide gel, and SDS-PAGE was 
performed as previously described. After gel staining, bands were manually excised, 
destained,  reduced,  alkylated,  and  finally  subjected  to  in  situ tryptic  digestion  as 
previously  described  (Addis  et  al.,  2009).  Peptide  mixtures  were  identified  by 
nanoHPLC-nanoESI-Q-TOF-analysis.  One-dimensional  patterns  were  analyzed  with 
Quantity One software (Bio-Rad).
4.12 MALDI-MS
Mass  spectra  were  recorded  on  a  MALDI micro  (Waters,  Manchester,  UK) 
equipped with a reflectron analyser and used in delayed extraction mode, as described 
previously  [56].  Peptide samples  were  mixed  with  an  equal  volume  of  α-cyano-4-
hydroxycynnamic acid as matrix  (10 mg/mL in acetonitrile/0.2% TFA) (70:30,  v/v), 
applied to the metallic sample plate, and air dried. Mass calibration was performed by 
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using  the  standard  mixture  provided  by  manufacturer.  Raw  data,  reported  as 
monoisotopic  masses,  were  then  introduced  into  the  in-house  Mascot  Peptide  Mass 
Fingerprinting  software  (Version  2.2,  Matrix  Science,  Boston,  MA),  and  used  for 
protein  identification.  Search  parameters  were  as  follows:  fixed  modifications 
carbamidomethyl (C), variable modifications pyro-Glu (N-term Q) and oxidation (M), 
peptide tolerance 80 ppm, enzyme trypsin, allowing up to 2 missed cleavages.
4.13 LC-MS/MS
LC-MS/MS analyses of tryptic digests were performed on a Q-TOF hybrid mass 
spectrometer equipped with a nano lock Z-spray source,  and coupled on-line with a 
capillary  chromatography  system  CapLC  (Waters,  Manchester,  UK),  as  described 
previously (Addis et al., 2009). After loading, the peptide mixture was first concentrated 
and washed at 20 µL/min onto a reverse-phase pre-column (Symmetry 300, C18, 5 µm, 
NanoEase, Waters) using 0.2% formic acid as eluent. The sample was then fractionated 
onto a C18 reverse-phase capillary column (Nanoflow column 5 μm Biosphere C18, 75 
µm x 200 mm, Nanoseparations) at a flow rate of 250 nL/min, using a linear gradient of  
eluent  B  (0.2%  formic  acid  in  95%  acetonitrile)  in  A  (0.2%  formic  acid  in  5% 
acetonitrile) from 2 to 40% in 27 min.  The mass spectrometer was set up in a data-
dependent MS/MS mode where a full scan spectrum (m/z acquisition range from 400 to 
1600 Da/e) was followed by tandem mass spectra (m/z acquisition range from 100 to 
2000 Da/e). Peptide ions were selected as the three most intense peaks of the previous 
scan. A suitable collision energy was applied depending on the mass and charge of the 
precursor ion. Argon was used as the collision gas. Mass calibration was conducted on 
the Glu-fibrino peptide B (Sigma) fragmentation pattern. ProteinLynx software (Version 
2.2.5), provided by the manufacturers, was used to analyze raw MS and MS/MS spectra 
and to generate a peak list which was introduced in the in-house Mascot MS/MS ion 
search software (Version 2.2, Matrix Science, Boston, MA) for protein identification. 
NCBI  was  used  as  sequence  database.  Search  parameters  were  as  follows:  fixed 
modifications  carbamidomethyl  (C), variable modifications  pyro-Glu (N-term Q) and 
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oxidation (M), peptide tolerance 30 ppm, MS/MS tolerance 0.3 Da, charge state +2 and 
+3, enzyme trypsin, allowing up to 1 missed cleavage.
4.14 Data analysis
MS data were subjected to gene ontology analysis with Blast2GO, using default 
parameters  (Götz  et  al.,  2008).  Identified  proteins  were  divided  into  classes  for 
functional  and  localization  analysis;  data  produced  by  the  software  were  used  for 
generation of graphs by Microsoft Excel.
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5. RESULTS
5.1 Species identification
FS1-FS2 PCR confirmed that  all  field isolates  and strains  used in  this  study 
belonged to M. agalactiae species (Fig.8).
Figure 8: FS1-FS2 PCR on M. agalactiae isoletes. 1-4: M. agalactiae PG2T strain; 5-6: M. agalactiae 
Bortigali field strain; 7-8: M. agalactiae Nurri field strain.
5.2 Extraction of bacterial proteins and isolation of liposoluble proteins
This study was aimed to the systematic characterization of M. agalactiae PG2T 
membrane proteins by means of a gel-based proteomic approach. In order to increase 
coverage for liposoluble proteins, the Triton X-114 fractionation method was chosen. 
Figure  9A  illustrates  the  hydrosoluble  and  liposoluble  fractions  obtained  from  M. 
agalactiae PG2T, flanked by the total protein pattern for comparison. The efficiency of 
the  procedure  in  separating  liposoluble  proteins  was  evaluated  by  Western 
immunoblotting using a rabbit hyperimmune serum raised against M. agalactiae rP48, a 
previously characterized surface lipoprotein (Rosati  et al., 1999, 2000). As expected, 
presence of P48 was observed only in the total extract and in the Triton X-114 phase 
(Figure  9B),  confirming  that  the  fractionation  method  enabled  separation  and 
enrichment of hydrophobic proteins.
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Figure  9: Total  protein patterns and Western immunoblotting reactivity  of  M. agalactiae PG2T 
proteins. Panel A. Coomassie blue staining. Panel B: Immunoblotting reactivity obtained with antibodies 
against the P48 lipoprotein.  From left to right: M: molecular weight standards (kDa);  T: total protein 
pattern;  H:  hydrosoluble protein fraction;  L:  liposoluble protein fraction obtained  after  Triton X-114 
fractionation
5.3 2-D PAGE/MS of M. agalactiae PG2T liposoluble proteins
Total proteins and the Triton X-114 soluble fraction of M. agalactiae PG2T were 
subjected to 2-D PAGE separation in order to evaluate the extent of enrichment in basic 
and liposoluble proteins. As illustrated in Figure 10A, a very high number of spots were 
present in the total protein map of M. agalactiae PG2T but, as expected, basic proteins 
were poorly represented.  Upon comparison,  the 2-D PAGE map generated with the 
Triton X-114 soluble fraction showed a significant enrichment in basic proteins, with an 
excellent resolution also in high-abundance spots (Figure 10B).
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Figure 10:  2-D Page patterns of  M. agalactiae  PG2T protein extracts. Panel A: 2-D PAGE of a  M. 
agalactiae PG2T total protein extract. Panel B: 2-D PAGE of  M. agalactiae PG2T liposoluble proteins 
obtained upon Triton X-114 fractionation.
In order to attain a systematic characterization of the liposoluble proteome, the 
Triton X-114 phase fraction of M. agalactiae PG2T was subjected to 2-D PAGE under 
three different pI intervals: 3-10NL, 7-11, and 4-7 (Supplementary data S1, S2, and S3). 
From these 2D maps, about 300 spots were excised and identified by MALDI-TOF and 
nanoHPLC-nanoESI-Q-TOF MS. This approach led to the successful identification of 
40 unique proteins, corresponding to 5.4% of all M. agalactiae PG2T genes. Figure 11 
reports  a  representative  liposoluble  protein  map  summarizing  the  main  protein 
identifications accomplished on 2-D spots.
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Figure 11: 2-D PAGE map of M. agalactiae PG2T liposoluble proteins illustrating protein identifications obtained by mass spectrometry. Proteins are indicated 
by grouping all individual identifications corresponding to the same protein in a series of spots.
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A detailed description of all  protein identifications  is  given in  supplementary 
data  S4.  Experimentally  deduced  molecular  weight  and  pI of  protein  spots  were 
compared  with  the  theoretical  parameters  obtained  from  MASCOT,  and  most 
experimental  data  were  in  accordance  with  theoretical  data.  Few  proteins,  such  as 
VpmA,  were  detected  in  multiple  spots  at  different  pIs  and  molecular  weights,  as 
expected for this class of lipoproteins which undergo size variation. The well-known 
immunogenic proteins (Tola et al., 1996; Rosati  et al., 1999, 2000; Glew et al., 2000; 
Fleury et al., 2002) were all detected by 2-D PAGE at the expected pI and MW. All six 
variable  surface  lipoproteins  encoded in  the  M. agalactiae PG2T genome  were  also 
detected, some of which (such as VpmaY and VpmaD) with high expression levels, as 
could  be  expected  considering  their  relevance  in  providing  variability  to  the 
mycoplasmal antigenic mosaic.
5.4 2D DIGE of liposoluble proteins among the type strain and two field isolates of 
M. agalactiae
In order to assess the suitability of 2-D PAGE for comparison of the membrane 
protein composition,  the liposoluble protein profiles of  M. agalactiae PG2T and two 
field isolates were compared by 2D DIGE (Fig 12).
The images generated upon acquisition of the single colour channels enable to evaluate 
the liposoluble protein profiles separately (Fig. 12, A, B, C), while comparison of two 
protein profiles can be performed upon superimposition of two colour signals (Fig. 12, 
D, E, F). In the overlay image, the three proteome 2D maps can be compared. Although 
many spots are shared among the three profiles (in white), a number of differences in 
expression can be appreciated. In fact, several spots are present only in one (blue, green, 
red) or two profiles (purple, yellow, light blue). Many already known antigens (such as 
P80, P48, P40, and most Vpmas) appear in white,  indicating superimposition of the 
three signals and therefore presence in all three bacterial proteomes.
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Figure  12: 2D DIGE of  liposoluble  proteins  extracted  from M.  agalactiae PG2T and two  field 
strains. Overlay image: image generated from the superimposition of the signals generated by the three 
samples. White indicates presence of the protein spot in all three isolates. Panels A, B, and C represent 
isolates PG2T,  Nurri,  and Bortigali,  respectively.  Panels D, E, and F represent the superimposition of 
Nurri/Bortigali, PG2T/Nurri, and PG2T/Bortigali, respectively.
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Several differences among the three profiles can be easily observed; for example, 
the series of spots at 40 kDa corresponding to VpmaY (in purple in the overlay image, 
Fig. 12) is present only in two cases (PG2T and Bortigali) while the series of spots at 23 
kDa (in green) is present only in one case (Nurri). The application of this method to an 
adequate number of isolates might enable to easily detect constantly expressed proteins 
that might serve as candidate antigens for development of vaccines and diagnostic tools.
5.5 GeLC-MS/MS of M. agalactiae PG2T liposoluble proteins
Although  well  suited  for  lipoprotein  analysis,  the  2-D  PAGE/MS  strategy 
presents drawbacks in analysis of transmembrane proteins, such as permeases or other 
highly hydrophobic proteins. Moreover, these protein classes may undergo selective loss 
during precipitation/resolubilization steps. In order to increase the membrane protein 
coverage and minimize selective protein loss, SDS-PAGE and GeLC-MS/MS analysis 
were performed on the non-precipitated Triton X-114 liposoluble protein fraction.
Figure  13:  Protein profile of liposolubile proteins before and after precipitation. Right: approach 
used  for  GeLC-MS/MS characterization.  The  bars  indicate  the  regions  cut  from the  PAGE gel  and  
subjected to mass spectrometry characterization. Protein identifications are reported in Supplementary 
data S6, from top to bottom.
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A  total  of  36  slices  were  cut  from the  SDS-PAGE gel  lane  containing  the 
separated liposoluble proteins  (Fig. 12) and subjected to nanoHPLC-nanoESI-Q-TOF-
MS/MS identification.
Upon application of this method, 194 mycoplasma proteins were identified in 
total,  corresponding to 26% of all  M. agalactiae PG2T genes, 38 of which were also 
identified  by  2-D  PAGE/MS  (for  a  detailed  list  of  protein  identifications,  see 
Supplemtary data S6;  Supplementary data S7 reports a summary table listing all unique 
protein identifications).
5.6 Data analysis and classification
A gene ontology (GO) classification was carried out on proteins identified by 2-
D PAGE/MS and GeLC-MS/MS. For the first method, proteins (n = 40) were mostly 
classified by the GO software as hypothetical lipoproteins (65%), cytoplasmic proteins 
(22%),  ribosomal  proteins  (8%),  and  other  membrane-located  proteins  (5%).  When 
identifications obtained by GeLC-MS/MS were also included in the GO analysis (n = 
194), 43% of all  identifications were assigned to proteins located on the membrane, 
either  lipoproteins  (17%)  or  other  membrane  proteins  (26%),  whereas  36%  were 
classified as cytoplasmic, 17% as ribosomal, and 4% of unknown localization (Fig. 13).
Figure 13: GO graph of proteins identified by 2-D PAGE-MS and GeLC-MS/MS in the Triton X-
114  fraction  of  M.  agalactiae PG2T.  Protein  identifications  are  classified  according  to  cellular 
localization.
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All protein identifications were then classified according to function (Figure 14, 
and Supplementary data S7). As expected, a high proportion of the identified proteins 
perform  membrane  transport  functions  (about  16%),  and  belong  mostly  to  ABC 
transporters (13%). Transmembrane proteins, such as permeases, were detected only by 
means of GeLC-MS/MS. Another highly represented functional process was translation 
(19%), due to the elevated number of ribosomal proteins identified. Hydrolytic enzymes 
were also significantly represented (6%), highlighting their crucial role for survival of 
mycoplasmas. Several other functional classes, such as enzymes involved in amino acid, 
carbohydrate, lipid, and nucleic acid metabolism, were significantly represented in the 
M. agalactiae PG2T liposoluble protein fraction. Secretion/export systems accounted for 
4% of all identified proteins; these components are in fact crucial for maturation and 
release of secreted proteins, but also for positioning/exposing lipoproteins on the outer 
side  of  the  bacterial  cell.  About  19% of  proteins  could  not  be  assigned  a  specific 
function by manual searches or GO classification.
Figure  14:  GO graph of proteins identified by GeLC-MS/MS in the Triton X-114 fraction of  M. 
agalactiae PG2T. Protein identifications are classified according to function.
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Proteomic  data  were analyzed in  order  to  investigate  presence of  liposoluble 
proteins resulting from expression of horizontally-transferred genes  (Sirand-Pugnet  et  
al., 2007). Among 194 identified proteins, 15 (7.8%) were acquired by HGT from the 
Mycoplasma mycoides cluster (Supplemtary data S8), while 7 (3.7%) were acquired by 
HGT from other bacteria (Supplemtary data S9), for a total of 22 proteins, making up to 
11.5% of all expressed membrane proteins being derived from putative HGT events.
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6. DISCUSSION
Gathering  proteomic  information  on  prokaryotic  membranes  is  a  challenging 
task, due to difficulties in cell fractionation and to the intrinsic chemical properties of 
membrane proteins  in  general.  Therefore,  both systematic  and differential  proteomic 
information  on  prokaryotic  membranes  is  generally  lacking.  In  this  work,  we 
approached the systematic characterization of what is believed to be one of the simplest 
bacterial  pathogen  membranes,  in  an  attempt  to  move  a  step  forward  in  our 
understanding of  its  composition,  complexity,  and function.  In addition  to  its  lower 
complexity, investigating membrane composition and plasticity in mycoplasmas is of 
particular interest since surface proteins are subjected to size and phase variation, and 
information  on the  extent  and level  of  such variation  is  crucial  in  studies  targeting 
identification  of  common  immunogens,  evaluation  of  immunological  escape 
mechanisms,  and  adaptation  of  the  bacterium  to  its  host.  All  6  variable  surface 
lipoproteins encoded in the PG2T genome (Sirand-Pugnet et al., 2007) were detected by 
2-D  PAGE,  although  one  of  these  (VpmaY)  was  not  expressed  in  a  field  isolate 
examined  by  2D  DIGE.  Triplicate  experiments  showed  that  the  two-dimensional 
expression pattern of each field isolate is relatively stable under laboratory conditions, 
and that there is a reproducible differential expression of several protein spots in the 
field isolates compared to the type strain PG2. Interestingly, these differences are being 
detected  in  bacteria  which  were  grown in  culture  media,  where  all  protein  variants 
should  theoretically  be  expressed  (Sirand-Pugnet  et  al.,  2007).  It  was  already 
demonstrated that the switching mechanism is so fast that it  can be pointed out in a 
single colony on solid culture (Chopra-Dewasthaly et al., 2008). This might suggest that 
the lack of VpmaY in the isolate Nurri could result from a local genetic mutation. A 
large-scale  study performed  on  a  higher  number  of  field  isolates  might  enable  the 
detection  of  constantly expressed proteins,  which might  be useful  as  targets  for  the 
development of vaccines and diagnostic tools for CA.
Mycoplasmas have evolved a parasitic lifestyle, and membrane transporters are 
consequently very important for uptake of nutrients and growth factors. The genome of 
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M. agalactiae PG2T encodes 18 ABC transporters, but proteins from only 10 of these 
were identified in this study. We also failed to identify all the components of a complete 
membrane transporter complex; however, it is possible that expression of all sequences 
encoded by the transporter gene operon may not necessarily take place at the same time. 
ABC transporters components encoded by different operons may likely interact to form 
functional  transporters,  producing  the  further  advantage  of  creating  many  different 
combinations that can help evasion of host defence mechanisms. For instance, the  M. 
agalactiae PG2T genome encodes for two oligopeptide (Opp) ABC transporters, one 
typical of the hominis group and one probably transferred by means of horizontal gene 
transfer  mechanisms  from  M. mycoides subsp.  mycoides and  M. capricolum subsp. 
capricolum. We identified the substrate binding protein (OppA) from one operon, and 
the  permease  (OppC)  and  the  ATP-binding  protein  (OppF)  from  another  operon; 
notably, these proteins create a functional transporter. Moreover, OppA could be more 
than a simple substrate binding protein, since it was demonstrated to play an important 
role in pathogenicity in  M. hominis by inducing ATP release and cell death of HeLa 
cells in vitro and by mediating adhesion to host cells (Henrich et al., 1999; Hopfe and 
Henrich, 2004, 2008). Other authors reported a different pattern of expression of these 
operons: in the study by Nouvel and co-workers, only OppA, OppF, and OppD were 
detected (Nouvel  et al., 2010). These apparently controversial results could be due to 
technical issues, or be dependent on variations in expression of Opps within the PG2T 
strain. This will need to be elucidated in future studies.
Upon  analysis  of  all  MS  data,  the  proteins  putatively  assigned  by the  GO 
software  as  cytoplasmic  accounted  to  36%.  Among  these,  many  hydrolases  were 
present.  However,  lipases,  peptidases,  and  nucleases  might  be  associated  to  the 
membrane compartment and assist in reducing macromolecules to simple components, 
enabling their uptake. In fact, mycoplasmas lack many biosynthetic pathways and rely 
on internalization  of  nucleotides,  amino  acids,  sugars  and lipids  from their  external 
environment. Recently, it was reported that hydrolytic enzymes are surface-located in 
mycoplasmas, and that they can be associated with ABC transporters in order to digest 
macromolecules  before  uptake  of  simpler  components,  or  play  major  roles  in 
Dott.ssa Carla Cacciotto, Characterization of Mycoplasma agalactiae membrane proteome.
Tesi di Dottorato in Scienze Biomolecolari e Biotecnologiche, Università degli Studi di Sassari.
pathogenicity (Schmidt  et al.,  2007). Interestingly, in the  M. agalactiae genome, the 
genes coding for many of these hydrolases are also located close to ABC transporter 
operons.
Several other proteins have a predicted cytoplasmic localization, but could be 
membrane-associated in mycoplasmas, such as the elongation factor tu (EF-Tu) and the 
E1  beta  subunit  of  the  pyruvate  dehydrogenase  complex.  Traditionally,  these  are 
considered  to  be  cytoplasmic  proteins  involved  in  protein  synthesis  and  energy 
production, respectively, but it was demonstrated that in M. pneumoniae they are surface 
exposed  and interact  with  host  fibronectin,  mediating  adhesion  (Dallo  et  al.,  2002; 
Balasubramanian  et  al.,  2008).  It  was  also  demonstrated  that  many  “cytoplasmic” 
proteins such as the EF-Tu are strong antigens in many mycoplasma species (Alonso et  
al., 2002; Bercic et al., 2008; Jores et al., 2009).
Ribosomal  proteins  represent  a  significant  proportion  of  the  mycoplasma 
liposoluble proteome. This might appear inconsistent, but in spite of their traditionally 
cytoplasmic localization, it was already demonstrated that ribosomes interact with the 
bacterial protein export complex (Johnson, 2009). Moreover, it is well known that in 
eukaryotes ribosomes are associated with endoplasmic reticulum, where they participate 
in the protein secretion pathway (White and  von Heijne, 2008). Several proteins that 
take part in other metabolic pathways were also identified in the liposoluble fraction of 
M.  agalactiae PG2T.  We  could  speculate  that  many  proteins  involved  in  nutrient 
metabolism might  associate  with proteins  devoted to  internalization of precursors in 
metabolizing complexes, and be co-purified with these. Nonetheless, a pre-fractionation 
of  membranes  was not  performed because of  inherent  technical  difficulties,  and we 
cannot rule out that enzymes with high hydrophobicity might be present as cytoplasmic 
contaminants.
The recent work by Sirand-Pugnet and coworkers revealed the occurrence of 
horizontal  gene transfer  (HGT) events  in  M. agalactiae.  The expression  of  proteins 
acquired by HGT highlights the importance of horizontal gene flow for the evolutionary 
plasticity  of  mycoplasmas;  for  instance,  by allowing  changes  in  host  and/or  tissue 
tropism through acquisition of traits enabling colonization and survival in new niches 
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(Marenda  et al.,  2006; Sirand-Pugnet  et al.,  2007). In total,  an impressing 11.7% of 
proteins  expressed on the  M. agalactiae membrane are coming from other  bacteria, 
reinforcing the view that an important part in the evolution of mycoplasmas might be 
driven by genetic exchange with bacteria sharing the same host districts, probably in 
order to compensate the concurrent process of gene loss (Sirand-Pugnet  et al., 2007). 
Another  interesting  observation  was  the  detection  of  MAG_2340,  a  hypothetical 
lipoprotein  which  is  apparently the  result  of  an  horizontal  gene  transfer  event  with 
mycoplasmas of the mycoides cluster (Supplemtary data S8), which was not detected by 
Nouvel et al. in the PG2T liposoluble proteome.
Hypothetical  proteins  were of particular  interest;  since these did not  have an 
assigned function,  similarity searches were conducted with BLAST tools in order to 
infer their possible role in the biology of mycoplasmas. Among these, the hypothetical 
lipoprotein MAG_1670 belongs to the mycoides cluster LppA/P72 family, and it is an 
antigen  recognized  early  and  persistently  in  infection  (Cheng  et  al.,  1996).  The 
hypothetical  protein  MAG_0250  has  an  indigoidine  synthase  A  (IdgA)-like  domain 
similar to  Clostridium spp. IdgA is involved in the biosynthesis of indigoidine, a blue 
pigment  synthesized  by  Erwinia  chrysanthemi and  implicated  in  pathogenicity  and 
protection from oxidative stress by scavenging oxygen radicals (Reverchon et al., 2002). 
Indigoidine  production  increases  tolerance  to  oxidative  stress  and  contributes  to 
aggressiveness, and might therefore act as a virulence factor.
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7. CONCLUSIONS
2-D  PAGE  studies  might  be  extremely  powerful  for  comparison  of  protein 
expression  in  different  mycoplasma  isolates,  especially  when  considering  that 
lipoproteins  can  be  selectively  detected  with  this  method,  and  that  size  and  phase 
variations  can  be  easily  spotted  through  the  application  of  powerful  differential 
comparison approaches as the 2D DIGE. However,  these need to be integrated with 
traditional  Western  immunoblotting  and  GeLC-MS/MS  for  a  deeper  coverage  and 
characterization  of  other  mycoplasmal  surface  immunogens  to  be  used  as  tools  for 
vaccination, diagnosis, and therapy. This combined approach allowed the identification 
and characterization of 194 M. agalactiae proteins putatively localized on the membrane 
or associated to it, providing useful insights on its composition. In the future, alternative 
approaches  such as blue native electrophoresis  and chemical  crosslinking of  surface 
proteins  will  also enable to  elucidate  functional  and structural  aspects of membrane 
proteins that cannot be accounted for by the traditional gel-based proteomic approaches.
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8. SUPPLEMENTARY DATA
S1: 2-D PAGE map of liposoluble proteins from  M. agalactiae PG2T illustrating the 
protein identifications obtained by MS on the 3-10NL pI Interval.
S2:  2-D PAGE map of liposoluble proteins from M. agalactiae PG2T illustrating the 
protein identifications obtained by MS on the 7-11 pI interval.
S3: 2-D PAGE map of liposoluble  proteins from M. agalactiae PG2T illustrating the 
protein identifications obtained by MS on the 4-7 pI interval
S4: Table listing all protein identifications obtained from 2-D PAGE maps.
S5: Protein profile of liposolubile proteins before and after precipitation.
S6:  Table  listing  all  protein  identifications  obtained  by  GeLC-MS/MS  of  the  M. 
agalactiae PG2T Triton X-114 liposoluble fraction.
S7:  Functional  analysis,  number  of  peptide  hits,  and  method  of  detection  of  M. 
agalactiae PG2T liposoluble proteins.
S8: Proteins identified in the  M. agalactiae PG2T proteome potentially resulting from 
Horizontal Gene Transfer events with M. mycoides subsp. mycoides and M. capricolum 
subsp. capricolum.
S9: Proteins identified in the  M. agalactiae PG2Tproteome potentially resulting from 
Horizontal Gene Transfer events with other bacteria.
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S1: 2-D PAGE map of liposoluble proteins from M. agalactiae PG2T illustrating the protein identifications obtained by MS on the 3-10NL pI Interval.
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S2: 2-D PAGE map of liposoluble proteins from M. agalactiae PG2T illustrating the protein identifications obtained by MS on the 7-11 pI interval
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S3: 2-D PAGE map of liposoluble proteins from M. agalactiae PG2T illustrating the protein identifications obtained by MS on the 4-7 pI interval
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S4: Table listing all protein identifications obtained from 2-D PAGE maps. The proteins listed in this table were identified from 2-D 
PAGE maps of the M. agalactiae PG2T Triton X-114 fraction . Maps are represented in supplementary data S1 (pH 3-10NL), S2 (pH 7-11), 
and S3 (pH 4-7).
Spot Map Protein Organism Mw (Da) pI Score Instrument Queries Coverage Acc. No. Locus tag
PG1 S1 NI
PG2 S1 NI
PG3 S1 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 155 MALDI-TOF 21 25% gi|148377368 MAG_1000
PG4 S1 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 71 MALDI-TOF 10 18% gi|148377368 MAG_1000
PG5 S1 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 175 MALDI-TOF 24 25% gi|148377368 MAG_1000
PG6 S1 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 199 MALDI-TOF 23 25% gi|148377368 MAG_1000
PG7 S1 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 91 MALDI-TOF 13 11% gi|148377368 MAG_1000
PG8 S1 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 168 MALDI-TOF 20 23% gi|148377368 MAG_1000
PG9 S1 P80. lipoprotein M. agalactiae PG2 81102 9.08 200 MALDI-TOF 24 37% gi|148377765 MAG_5030
PG9bis S1 P80. lipoprotein M. agalactiae PG2 81102 9.08 74 ESI Q-TOF 5 6% gi|148377765 MAG_5030
PG10 S1 P80. lipoprotein M. agalactiae PG2 81102 9.08 136 ESI Q-TOF 10 11% gi|148377765 MAG_5030
PG11 S1 P80. lipoprotein M. agalactiae PG2 81102 9.08 181 MALDI-TOF 23 35% gi|148377765 MAG_5030
PG12 S1 5'nucleotidase M. agalactiae PG2 76195 8.36 72 MALDI-TOF 7 15% gi|148377854 MAG_5910
PG13 S1 5'nucleotidase M. agalactiae PG2 76195 8.36 96 MALDI-TOF 10 17% gi|148377854 MAG_5910
PG13bis S1 5'nucleotidase M. agalactiae PG2 76195 8.36 113 MALDI-TOF 10 18% gi|148377854 MAG_5910
PG14 S1 Hypothetical protein MAG_6520 M. agalactiae PG2 70087 8.58 64 MALDI-TOF 8 14% gi|148377915 MAG_6520
PG14bis S1 Hypothetical protein MAG_6520 M. agalactiae PG2 70087 8.58 59 MALDI-TOF 6 15% gi|148377915 MAG_6520
PG15 S1 NI
PG16 S1 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 73 MALDI-TOF 8 17% gi|148377488 MAG_2220
PG17 S1 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 141 MALDI-TOF 16 28% gi|148377488 MAG_2220
PG18 S1 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 149 MALDI-TOF 13 33% gi|148377488 MAG_2220
PG19 S1 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 110 MALDI-TOF 12 28% gi|148377488 MAG_2220
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PG20 S1 Hypothetical protein MAG_6520 M. agalactiae PG2 70087 8.58 64 MALDI-TOF 8 18% gi|148377915 MAG_2220
PG21 S1 NI
PG22 S1 NI




PG27 S1 Lipoprotein, MAG_5080 M. agalactiae PG2 59415 6.77 94 MALDI-TOF 10 20% gi|148377770 MAG_5080
PG28 S1 Lipoprotein, MAG_5080 M. agalactiae PG2 59415 6.77 65 MALDI-TOF 7 18% gi|148377770 MAG_5080





PG34 S1 Variable surface lipoprotein V M. agalactiae PG2 37362 9.25 56 ESI Q-TOF 2 5% gi|148377967 MAG_7050
Variable surface lipoprotein U M. agalactiae PG2 46993 9.26 56 ESI Q-TOF 2 4% gi|32189693 MAG_7090
PG35 S1 Variable surface lipoprotein V M. agalactiae PG2 37362 9.25 108 ESI Q-TOF 7 14% gi|148377967 MAG_7050
Variable surface lipoprotein U M. agalactiae PG2 46993 9.26 108 ESI Q-TOF 7 11% gi|32189693 MAG_7090
PG36 S1 Variable surface lipoprotein V M. agalactiae PG2 37362 9.25 42 ESI Q-TOF 1 2% gi|148377967 MAG_7050
Variable surface lipoprotein U M. agalactiae PG2 46993 9.26 42 ESI Q-TOF 1 2% gi|32189693 MAG_7090
PG37 S1 Lipoprotein, MAG_1980 M. agalactiae PG2 53788 8.98 69 MALDI-TOF 7 15% gi|148377464 MAG_1980
PG38 S1 Lipoprotein, MAG_1980 M. agalactiae PG2 53788 8.98 88 MALDI-TOF 9 19% gi|148377464 MAG_1980
PG39 S1 Alkylphosphonate ABC transporter substrate-binding protein M. agalactiae PG2 49744 6.99 95 MALDI-TOF 9 22% gi|148377535 MAG_2690
PG40 S1 Alkylphosphonate ABC transporter substrate-binding protein M. agalactiae PG2 49744 6.99 73 MALDI-TOF 7 17% gi|148377535 MAG_2690
PG41 S1 P48. lipoprotein M. agalactiae PG2 51232 8.39 62 MALDI-TOF 5 17% gi|148377280 MAG_0120
PG42 S1 P48. lipoprotein M. agalactiae PG2 51232 8.39 114 MALDI-TOF 10 25% gi|148377280 MAG_0120
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PG43 S1 P48. lipoprotein M. agalactiae PG2 51232 8.39 125 MALDI-TOF 12 33% gi|148377280 MAG_0120
PG44 S1 P48. lipoprotein M. agalactiae PG2 51232 8.39 137 MALDI-TOF 11 33% gi|148377280 MAG_0120
PG45 S1 P48. lipoprotein M. agalactiae PG2 51232 8.39 98 MALDI-TOF 9 25% gi|148377280 MAG_0120
PG46 S1 P48. lipoprotein M. agalactiae PG2 51232 8.39 81 MALDI-TOF 7 19% gi|148377280 MAG_0120
PG47 S1 Variable surface lipoprotein V M. agalactiae PG2 37362 9.25 40 ESI Q-TOF 1 2% gi|148377967 MAG_7050
Variable surface lipoprotein U M. agalactiae PG2 46993 9.26 40 ESI Q-TOF 1 2% gi|32189693 MAG_7090
PG48 S1 NI
PG49 S1 Hypothetical protein MAG_5040 M. agalactiae PG2 44828 8.46 96 MALDI-TOF 8 26% gi|148377766 MAG_5040
PG50 S1 Hypothetical protein MAG_5040 M. agalactiae PG2 44828 8.46 104 MALDI-TOF 8 30% gi|148377766 MAG_5040
PG51 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 81 MALDI-TOF 7 30% gi|148377970 MAG_7080
PG52 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 88 MALDI-TOF 7 25% gi|148377970 MAG_7080
PG53 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 55 MALDI-TOF 5 24% gi|148377970 MAG_7080
PG54 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 55 MALDI-TOF 5 24% gi|148377970 MAG_7080
PG55 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 72 MALDI-TOF 7 28% gi|148377970 MAG_7080
PG56 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 69 MALDI-TOF 7 31% gi|148377970 MAG_7080
PG57 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 56 MALDI-TOF 5 24% gi|148377970 MAG_7080
PG58 S1 Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 127 MALDI-TOF 10 30% gi|148377968 MAG_7060
PG59 S1 Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 87 MALDI-TOF 9 27% gi|148377968 MAG_7060
PG60 S1 Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 135 MALDI-TOF 11 31% gi|148377968 MAG_7060
PG61 S1 P40, lipoprotein M. agalactiae PG2 39951 8.19 40 ESI Q-TOF 2 5% gi|148377507 MAG_2410
PG62 S1 P40, lipoprotein M. agalactiae PG2 39951 8.19 80 MALDI-TOF 6 21% gi|148377507 MAG_2410
PG63 S1 P40, lipoprotein M. agalactiae PG2 39951 8.19 80 MALDI-TOF 6 21% gi|148377507 MAG_2410
PG64 S1 P40, lipoprotein M. agalactiae PG2 39951 8.19 118 MALDI-TOF 9 28% gi|148377507 MAG_2410
PG65 S1 NI
PG66 S1 P40, lipoprotein M. agalactiae PG2 39951 8.19 127 ESI Q-TOF 8 16% gi|148377507 MAG_2410
PG67 S1 P40, lipoprotein M. agalactiae PG2 39951 8.19 58 MALDI-TOF 6 19% gi|148377507 MAG_2410
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PG68 S1 Hypothetical protein MAG_1890 M. agalactiae PG2 36683 8.78 118 MALDI-TOF 9 34% gi|148377455 MAG_1890
PG69 S1 NI
PG70 S1 Glyceraldehyde-3-phosphate dehydrogenase A E. coli 35681 6.61 55 ESI Q-TOF 1 4% G3P1_ECO57
PG71 S1 NI
PG72 S1 Attachment protein M. genitalium 21972 5.35 30 ESI Q-TOF 1 5% gi|82906922
PG73 S1 NI
PG74 S1 Lipoprotein MAG_2430 M. agalactiae PG2 33862 8.29 56 MALDI-TOF 5 24% gi|148377509 MAG_2430
PG75 S1 ICEF-IIA ORF19 M. fermentans 81544 8.20 25 ESI Q-TOF 1 1% gi|26984117
PG76 S1 NI
PG77 S1 NI





PG83 S1 Lipoprotein MAG_1980 M. agalactiae PG2 53788 8.98 58 MALDI-TOF 5 13% gi|148377464 MAG_1980
PG84 S1 Variable surface lipoprotein V M. agalactiae PG2 37362 9.25 48 ESI Q-TOF 1 2% gi|23683074 MAG_7050
PG85 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 63 ESI Q-TOF 1 3% gi|148377970 MAG_7080
PG86 S1 Lipoprotein MAG_1050 M. agalactiae PG2 37025 9.26 56 MALDI-TOF 5 23% gi|148377373 MAG_1050
PG87 S1 Lipoprotein MAG_2430 M. agalactiae PG2 33862 8.29 139 MALDI-TOF 9 36% gi|148377509 MAG_2430
PG88 S1 Lipoprotein MAG_2430 M. agalactiae PG2 33862 8.29 149 MALDI-TOF 9 32% gi|148377509 MAG_2430
PG89 S1 NI
PG90 S1 Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 47 ESI Q-TOF 2 8% gi|148377389 MAG_1220
PG91 S1 Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 97 ESI Q-TOF 5 15% gi|148377389 MAG_1220
PG92 S1 Lipoprotein MAG_6200 M. agalactiae PG2 26952 9.22 86 ESI Q-TOF 7 28% gi|148377883 MAG_6200
Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 54 ESI Q-TOF 3 12% gi|148377389 MAG_1220
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Transcription Elongation factor 
GreA
M. capricolum subsp.  
capricolum ATCC 
27343
17483 5.84 33 ESI Q-TOF 1 5% gi|83319925
Lipoate-protein ligase A M. agalactiae PG2 37286 6.42 29 ESI Q-TOF 2 2% gi|148377329 MAG_0600
PG93 S1 Lipoprotein MAG_6200 M. agalactiae PG2 26952 9.22 30 ESI Q-TOF 3 11% gi|148377883 MAG_6200
PG94 S1 Lipoprotein MAG_6200 M. agalactiae PG2 26952 9.22 29 ESI Q-TOF 1 3% gi|148377883 MAG_6200
PG95 S1 Lipoprotein MAG_6200 M. agalactiae PG2 26952 9.22 72 ESI Q-TOF 3 13% gi|148377883 MAG_6200
PG96 S1 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 129 ESI Q-TOF 8 9% gi|148377972 MAG_7100
PG97 S1 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 60 MALDI-TOF 7 18% gi|148377972 MAG_7100
PG98 S1 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 77 MALDI-TOF 8 21% gi|148377972 MAG_7100
PG99 S1 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 190 ESI Q-TOF 7 11% gi|148377972 MAG_7100
PG100 S1 NI
PG101 S1 NI
PG102 S1 Lipoprotein MAG_2000 M. agalactiae PG2 26602 8.39 69 ESI Q-TOF 1 6% gi|148377466 MAG_2000
PG103 S1 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 138 ESI Q-TOF 7 25% gi|148377626 MAG_3600
PG104 S1 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 533 ESI Q-TOF 22 58% gi|148377626 MAG_3600
Endonuclease IV M. penetrans HF-2 35632 6.22 33 ESI Q-TOF 1 4% gi|26553573
PG105 S1 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 142 ESI Q-TOF 9 36% gi|148377626 MAG_3600
Endonuclease IV M. penetrans HF-2 35632 6.22 26 ESI Q-TOF 1 4% gi|26553573
PG106 S1 Lipoprotein MAG_2400 M. agalactiae PG2 38065 8.95 179 ESI Q-TOF 9 20% gi|148377506 MAG_2400
PG107 S1 NI
PG108 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 831 ESI Q-TOF 26 21% gi|148377970 MAG_7080
PG109 S1 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 153 ESI Q-TOF 3 6% gi|148377970 MAG_7080
PG110 S1 NI
PG111 S1 ATP synthase B chain M. agalactiae PG2 21796 9.4 50 ESI Q-TOF 1 6% gi|148377618 MAG_3520
PG112 S1 ATP synthase B chain M. agalactiae PG2 21796 9.4 29 ESI Q-TOF 1 6% gi|148377618 MAG_3520
PG113 S1 ATP synthase B chain M. agalactiae PG2 21796 9.4 27 ESI Q-TOF 1 6% gi|148377618 MAG_3520
PG114 S1 Variable surface lipoprotein A M. agalactiae PG2 24769 8.33 85 MALDI-TOF 5 29% gi|148377969 MAG_7070
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PG115 S1 NI
PG116 S1 Variable surface lipoprotein A M. agalactiae PG2 24769 8.33 60 MALDI-TOF 4 24% gi|148377969 MAG_7070
PG117 S1 Variable surface lipoprotein A M. agalactiae PG2 24769 8.33 62 MALDI-TOF 4 24% gi|148377969 MAG_7070
P-1 S2 NI
P-2 S2 NI
P-3 S2 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 155 MALDI-TOF 21 25% gi|148377368 MAG_1000
P-4 S2 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 71 MALDI-TOF 10 18% gi|148377368 MAG_1000
P-5 S2 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 175 MALDI-TOF 24 25% gi|148377368 MAG_1000
P-6 S2 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 199 MALDI-TOF 23 25% gi|148377368 MAG_1000
P-7 S2 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 91 MALDI-TOF 13 11% gi|148377368 MAG_1000
P-8 S2 P80. lipoprotein M. agalactiae PG2 81102 9.08 219 MALDI-TOF 23 35% gi|148377765 MAG_5030
P-9 S2 P80. lipoprotein M. agalactiae PG2 81102 9.08 181 MALDI-TOF 23 35% gi|13992493 MAG_5030
P-10 S2 P80. lipoprotein M. agalactiae PG2 81102 9.08 229 MALDI-TOF 23 35% gi|13992493 MAG_5030
P-11 S2 P80. lipoprotein M. agalactiae PG2 81102 9.08 245 MALDI-TOF 23 35% gi|13992493 MAG_5030
P-12 S2 NI
P-13 S2 5'nucleotidase M. agalactiae PG2 76195 8.26 83 ESI Q-TOF 10 14% gi|148377854 MAG_5910
P-14 S2 Hypothetical protein MAG_6520 M. agalactiae PG2 70087 8.58 62 ESI Q-TOF 4 6% gi|148377915 MAG_6520
Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 40 ESI Q-TOF 6 8% gi|148377488 MAG_2220
P-15 S2 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 76 MALDI-TOF 9 22% gi|148377488 MAG_2220
P-16 S2 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 59 MALDI-TOF 6 17% gi|148377488 MAG_2220
P-17 S2 NI
P-18 S2 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 96 MALDI-TOF 11 24% gi|148377488 MAG_2220
P-19 S2 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 55 MALDI-TOF 6 14% gi|148377488 MAG_2220
P-20 S2 P48. lipoprotein M. agalactiae PG2 51232 8.39 56 MALDI-TOF 7 21% gi|148377280 MAG_0120
P-21 S2 NI
P-22 S2 NI
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P-27 S2 Lipoprotein MAG_1980 M. agalactiae PG2 53788 8.98 73 MALDI-TOF 9 23% gi|148377464 MAG_1980













P-41 S2 Lipoprotein MAG_2350 M. agalactiae PG2 40383 8.61 ESI Q-TOF 13 35% gi|148291547 MAG_2350
Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 91 MALDI-TOF 10 27% gi|148377970 MAG_7080
P-43 S2 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 142 MALDI-TOF 13 38% gi|148377970 MAG_7080
P-44 S2 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 121 MALDI-TOF 10 35% gi|148377970 MAG_7080
P-45 S2 NI
P-46 S2 Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 82 MALDI-TOF 7 23% gi|148377968 MAG_7060
P-47 S2 Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 82 MALDI-TOF 7 21% gi|148377968 MAG_7060
P-48 S2 Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 82 MALDI-TOF 7 21% gi|148377968 MAG_7060
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P-49 S2 Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 94 MALDI-TOF 8 23% gi|148377968 MAG_7060
P-50 S2 Hypothetical protein MAG_1450 M. agalactiae PG2 35463 9.15 86 ESI Q-TOF 3 8% gi|148377412 MAG_1450
Lipoprotein MAG_1050 M. agalactiae PG2 37025 9.26 49 ESI Q-TOF 1 3% gi|148377373 MAG_1050
P-51 S2 5'nucleotidase M. agalactiae PG2 76195 8.26 52 ESI Q-TOF 3 3% gi|148377854 MAG_5910
P-52 S2 5'nucleotidase M. agalactiae PG2 76195 8.26 65 ESI Q-TOF 4 4% gi|148377854 MAG_5910
P-53 S2 Lipoprotein MAG_1050 M. agalactiae PG2 37025 9.26 76 MALDI-TOF 8 26% gi|148377373 MAG_1050
P-54 S2 Lipoprotein MAG_1050 M. agalactiae PG2 37025 9.26 233 MALDI-TOF 20 53% gi|148377373 MAG_1050
P-55 S2 Lipoprotein MAG_1050 M. agalactiae PG2 37025 9.26 203 MALDI-TOF 15 45% gi|148377373 MAG_1050
P-56 S2 Lipoprotein MAG_1050 M. agalactiae PG2 37025 9.26 57 MALDI-TOF 6 21% gi|148377373 MAG_1050
P-57 S2 Putative nicotinate-nucleotide adenylyltransferase
M. pneumoniae  
M129 40168 9.79 55 MALDI-TOF 6 24% gi|161723288
P-58 S2 Lipoprotein M. agalactiae PG2 37025 9.26 83 ESI Q-TOF 5 12% gi|148377373 MAG_1050
P-59 S2 Lipoprotein M. agalactiae PG2 37025 9.26 72 MALDI-TOF 6 26% gi|148377373 MAG_1050
P-60 S2 NI
P-61 S2 NI
P-62 S2 Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 28 ESI Q-TOF 1 3% gi|148377968 MAG_7060








P-71 S2 Lipoprotein MAG_6200 M. agalactiae PG2 26952 9.22 37 ESI Q-TOF 1 3% gi|148377883 MAG_6200
Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 30 ESI Q-TOF 1 3% gi|148377389 MAG_1220
P-72 S2 Lipoprotein MAG_6200 M. agalactiae PG2 26952 9.22 35 ESI Q-TOF 1 3% gi|148377883 MAG_6200
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S2 Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 ESI Q-TOF 1 3% gi|148377389 MAG_1220
P-73 S2 Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 35 ESI Q-TOF 1 3% gi|148377389 MAG_1220
P-74 S2 Lipoprotein MAG_6200 M. agalactiae PG2 26952 9.22 81 ESI Q-TOF 3 11% gi|148377883 MAG_6200
P-75 S2 NI







P-83 S2 50S ribosomal protein L1 M. agalactiae PG2 24955 9.68 62 ESI Q-TOF 1 4% gi|148377349 MAG_0810
P-84 S2 Hypothetical lipoprotein M. arthritidis 158L3-1 77114 8.42 28 ESI Q-TOF 1 1% gi|193217020
P-85 S2 NI
P-86 S2 NI
P-87 S2 Lipoprotein. MAG_4740 M. agalactiae PG2 25452 9.47 71 MALDI-TOF 8 37% gi|148377737 MAG_4740
P-88 S2 Lipoprotein MAG_4740 M. agalactiae PG2 25452 9.47 68 MALDI-TOF 6 27% gi|148377737 MAG_4740
P-89 S2 30S ribosomal protein S8 M. agalactiae PG2 24090 9.91 151 ESI Q-TOF 8 22% gi|148377803 MAG_5400
P-90 S2 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 70 ESI Q-TOF 2 9% gi|148377626 MAG_3600
P-91 S2 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 53 ESI Q-TOF 3 9% gi|148377626 MAG_3600
P-92 S2 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 150 ESI Q-TOF 5 15% gi|148377626 MAG_3600
P-93 S2 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 55 MALDI-TOF 5 35% gi|148377626 MAG_3600
P-94 S2 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 412 ESI Q-TOF 12 52% gi|148377626 MAG_3600
P-95 S2 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 64 MALDI-TOF 6 35% gi|148377626 MAG_3600
P-96 S2 Lipoprotein MAG_3600 M. agalactiae PG2 21678 9.13 57 MALDI-TOF 6 38% gi|148377626 MAG_3600
P-97 S2 NI
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P-98 S2 NI
P-99 S2 NI
P-100 S2 Lipoprotein MAG_2400 M. agalactiae PG2 38065 8.95 37 ESI Q-TOF 4 11% gi|148377506 MAG_2400
P-101 S2 Lipoprotein MAG_2400 M. agalactiae PG2 38065 8.95 111 ESI Q-TOF 11 15% gi|148377506 MAG_2400
P-102 S2 NI
P-103 S2 NI








P-112 S2 5'nucleotidase M. agalactiae PG2 76195 8.26 116 ESI Q-TOF 6 8% gi|148377854 MAG_5910
P-113 S3 Hypotetical protein MAG_1000 M. agalactiae PG2 109727 8.66 168 MALDI-TOF 20 23% gi|148377368 MAG_1000
P-114 S3 P80. lipoprotein M. agalactiae PG2 81102 9.08 200 MALDI-TOF 24 37% gi|148377765 MAG_5030
P-115 S3 5'nucleotidase M. agalactiae PG2 76195 8.36 91 MALDI-TOF 11 21% gi|148377854 MAG_5910
P-116 S3 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 85 MALDI-TOF 10 20% gi|148377488 MAG_2220
P-117 S3 P80. lipoprotein M. agalactiae PG2 81102 9.08 74 ESI Q-TOF 5 6% gi|148377765 MAG_5030
P-118 S3 P80. lipoprotein M. agalactiae PG2 81102 9.08 136 ESI Q-TOF 10 11% gi|148377765 MAG_5030
P-119 S3 Lipoprotein M. agalactiae PG2 59415 6.77 58 ESI Q-TOF 7 10% gi|148377770 MAG_5080
P-120 S3 NI
P-121 S3 Lipoprotein MAG_5080 M. agalactiae PG2 59415 6.77 395 ESI Q-TOF 17 30% gi|148377770 MAG_5080
P-122 S3 Lipoprotein MAG_5080 M. agalactiae PG2 59415 6.77 63 MALDI-TOF 6 17% gi|148377770 MAG_5080
P-123 S3 Lipoprotein MAG_5080 M. agalactiae PG2 59415 6.77 132 ESI Q-TOF 6 8% gi|148377770 MAG_5080
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P-124 S3 NI
P-125 S3 NI
P-126 S3 NADH oxidase (NOXASE) M. agalactiae PG2 49980 6.09 39 ESI Q-TOF 2 3% gi|148377529 MAG_2630
P-127 S3 NADH oxidase (NOXASE) M. agalactiae PG2 49980 6.09 33 ESI Q-TOF 2 3% gi|148377529 MAG_2630
P-128 S3 P48. lipoprotein M. agalactiae PG2 51232 8.39 46 ESI Q-TOF 2 4% gi|148377280 MAG_0120
P-129 S3 NI
P-130 S3 P48. lipoprotein M. agalactiae PG2 51232 8.39 149 ESI Q-TOF 5 10% gi|148377280 MAG_0120
P-131 S3 NI







P-139 S3 P48. lipoprotein M. agalactiae PG2 51232 7.19 149 ESI Q-TOF 5 10% gi|148377280 MAG_0120
P-140 S3 NI
P-141 S3 Elongation factor Tu M. agalactiae PG2 43638 5.89 195 MALDI-TOF 14 41% gi|148377586 MAG_3200
P-142 S3 Hypothetical protein MAG_5040 M. agalactiae PG2 44828 8.46 61 MALDI-TOF 9 21% gi|148377766 MAG_5040
P-143 S3 P40, lipoprotein M. agalactiae PG2 39951 8.2 113 MALDI-TOF 11 33% gi|148377507 MAG_2410
P-144 S3 P40, lipoprotein M. agalactiae PG2 39951 8.19 126 MALDI-TOF 11 33% gi|148377507 MAG_2410
P-145 S3 P40, lipoprotein M. agalactiae PG2 39951 8.19 118 MALDI-TOF 10 34% gi|148377507 MAG_2410
P-146 S3 P40, lipoprotein M. agalactiae PG2 39951 8.19 141 MALDI-TOF 11 37% gi|148377507 MAG_2410
P-147 S3 NI
P-148 S3 P40, lipoprotein M. agalactiae PG2 39951 8.19 105 MALDI-TOF 9 30% gi|148377507 MAG_2410
P-149 S3 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 34 ESI Q-TOF 3 10% gi|148377970 MAG_7080
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Spot Map Protein Organism Mw (Da) pI Score Instrument Queries Coverage Acc. No. Locus tag
P-150 S3 NI
P-151 S3 P40, lipoprotein M. agalactiae PG2 39951 8.19 136 ESI Q-TOF 6 16% gi|148377507 MAG_2410
Lipoate-protein ligase A M. agalactiae PG2 37286 6.42 25 ESI Q-TOF 1 2% gi|148377329 MAG_0600
P-152 S3 Pyruvate dehydrogenase E1 component. alphasubunit M. agalactiae PG2 41321 6.13 58 ESI Q-TOF 2 5% gi|148377361 MAG_0930
P-153 S3 NI
P-154 S3 Pyruvate dehydrogenase E1 component. betasubunit M. agalactiae PG2 36129 5.44 57 ESI Q-TOF 2 3% gi|148377362 MAG_0940
P-155 S3 Pyruvate dehydrogenase E1 component. betasubunit M. agalactiae PG2 36129 5.44 97 MALDI-TOF 10 41% gi|148377362 MAG_0940
P-156 S3 Pyruvate dehydrogenase E1 component. betasubunit M. agalactiae PG2 36129 5.44 120 MALDI-TOF 13 46% gi|148377362 MAG_0940
P-157 S3 Acyl carrier protein phosphodiesterase
M. hyopneumoniae  
232 25819 9.52 28 ESI Q-TOF 1 4% gi|54020205
P-158 S3 NI
P-159 S3 Triosephosphate isomerase M. hyopneumoniae  232 26804 8.33 29 ESI Q-TOF 1 3% gi|54020428
P-160 S3 D-lactate dehydrogenase M. agalactiae PG2 37021 6.11 34 ESI Q-TOF 1 2% gi|148377416 MAG_1490
P-162 S3 Lipoprotein MAG_2430 M. agalactiae PG2 33862 8.29 36 ESI Q-TOF 2 6% gi|148377509 MAG_2430
ICEF-IIA ORF19 M. fermentans 81544 8.2 25 ESI Q-TOF 1 1% gi|26984117
P-163 S3 Lipoprotein MAG_2430 M. agalactiae PG2 33862 8.29 73 MALDI-TOF 7 27% gi|148377509 MAG_2430
P-164 S3 Lipoprotein MAG_2430 M. agalactiae PG2 33862 8.29 120 MALDI-TOF 10 36% gi|148377509 MAG_2430
P-165 S3 Lipoprotein MAG_2430 M. agalactiae PG2 33862 8.29 117 MALDI-TOF 8 34% gi|148377509 MAG_2430
P-166 S3 Lipoprotein MAG_2430 M. agalactiae PG2 33862 8.29 72 MALDI-TOF 6 27% gi|148377509 MAG_2430
P-167 S3 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 30 ESI Q-TOF 1 2% gi|148377972 MAG_7100
P-168 S3 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 129 ESI Q-TOF 8 9% gi|148377972 MAG_7100
P-169 S3 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 60 MALDI-TOF 7 18% gi|148377972 MAG_7100
P-170 S3 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 77 MALDI-TOF 8 21% gi|148377972 MAG_7100
P-171 S3 Variable surface lipoprotein D M. agalactiae PG2 36608 9.53 190 ESI Q-TOF 7 11% gi|148377972 MAG_7100
P-172 S3 NI
P-173 S3 NI
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Spot Map Protein Organism Mw (Da) pI Score Instrument Queries Coverage Acc. No. Locus tag
P-174 S3 Variable surface lipoprotein A M. agalactiae PG2 24770 8.33 64 MALDI-TOF 5 31% gi|148377969 MAG_7070
P-175 S3 Variable surface lipoprotein A M. agalactiae PG2 24769 8.33 307 ESI Q-TOF 10 22% gi|148377969 MAG_7070
Dott.ssa Carla Cacciotto, Characterization of Mycoplasma agalactiae membrane proteome.
Tesi di Dottorato in Scienze Biomolecolari e Biotecnologiche, Università degli Studi di Sassari.
S5:  Protein profile of liposolubile proteins before and after precipitation. Right: approach used for GeLC-MS/MS characterization.  The bars indicate the 
regions cut from the PAGE gel and subjected to mass spectrometry characterization. Protein identifications are reported in supplementary data S6, from top to bottom. 
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S6: Table listing all protein identifications obtained by GeLC-MS/MS of the M. agalactiae PG2T Triton X-114 liposoluble fraction. 
The protein profile used and the number of slices are represented in supplementary data S5. 
Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus
1 Malate permease M. agalactiae PG2 45146 9.75 274 5 9%
gi|148377751
MAG_4890
Elongation factor Tu M. agalactiae PG2 43638 5.89 261 7 17%
gi|148377586
MAG_3200
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 189 6 18%
gi|148377752
MAG_4900
Sugar ABC transporter permease M. agalactiae PG2 74657 9.45 179 9 11%
gi|148377283
MAG_0150
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 176 3 5%
gi|148377767
MAG_5050
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 173 4 6%
gi|148377364
MAG_0960
NADH oxidase (NOXASE) M. agalactiae PG2 49980 6.09 161 6 15%
gi|148377529
MAG_2630
Putative inner membrane protein 
translocase component YidC
M. agalactiae PG2 83003 9.48 111 6 7%
gi|148377328
MAG_0590
Hypothetical protein MAG_0280 M. agalactiae PG2 75681 9.03 104 2 2%
gi|148377296
MAG_0280
Preprotein translocase subunit SecY M. agalactiae PG2 54823 9.7 102 2 3%
gi|148377788
MAG_5260
Cation-transporting P-type ATPase M. agalactiae PG2 100888 6.32 94 3 3%
gi|148377722
MAG_4590
ABC transporter. ATP-binding protein M. agalactiae PG2 68597 9.25 94 1 2%
gi|148377862
MAG_5990
Protein-export membrane protein M. agalactiae PG2 89106 9.52 82 5 5%
gi|148377491
MAG_2250
ABC transporter permease protein M. agalactiae PG2 39653 9.72 74 1 3%
gi|148377768
MAG_5060
ABC transporter. ATP-binding protein M. agalactiae PG2 67154 8.52 69 1 1%
gi|148377863
MAG_6000
ABC transporter. ATP-binding protein. 
P59
M. agalactiae PG2 58997 6.43 67 3 6%
gi|148377282
MAG_0140
Hypothetical protein MAG_2680 M. agalactiae PG2 55645 4.72 65 1 2%
gi|148377534
MAG_2680
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Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus
Oligopeptide ABC transporter system. 
permeaseprotein (OppC)
M. agalactiae PG2 47514 8.85 55 4 8%
gi|148377370
MAG_1020
DNA gyrase subunit A M. agalactiae PG2 103247 5.33 54 2 2%
gi|148377826
MAG_5630
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 52 1 3%
gi|148377362
MAG_0940
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 51 2 5%
gi|148377361
MAG_0930
ABC transporter permease protein M. agalactiae PG2 37630 9.89 47 1 2%
gi|148377769
MAG_5070
50S ribosomal protein L1 M. agalactiae PG2 24955 9.68 44 2 7%
gi|148377349
MAG_0810
Glycerol ABC transporter. ATP-binding 
protein
M. capricolum subsp. 
capricolum ATCC 
27343
47229 9.59 43 2 6%
gi|83319663
MCAP_0454
Ascorbate-specific PTS system enzyme 
IIC
M. agalactiae PG2 64257 9.33 42 1 3%
gi|148377901
MAG_6380
30S ribosomal protein S8 M. agalactiae PG2 24090 9.91 38 1 3%
gi|148377803
MAG_5400
50S ribosomal protein L2 M. agalactiae PG2 30773 10.63 38 2 4%
gi|148377806
MAG_5430
Cation-transporting P-ATPase M. agalactiae PG2 100451 8.6 31 1 1%
gi|148378004
MAG_7420
Hexosephosphate transport protein M. agalactiae PG2 54592 9.81 30 1 1%
gi|148377759
MAG_4970
Hypothetical protein MAG_4530 M. agalactiae PG2 52907 9.51 29 1 2%
gi|148377716
MAG_4530
ABC transporter. permease protein M. agalactiae PG2 71089 8.87 27 1 1%
gi|148377723
MAG_4600
Lipoate-protein ligase A M. agalactiae PG2 37286 6.42 26 2 2%
gi|148377329
MAG_0600
2 L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 121 5 14%
gi|148377752
MAG_4900
Hypothetical protein MAG_0280 M. agalactiae PG2 75681 9.03 116 2 2%
gi|148377296
MAG_0280
Malate permease M. agalactiae PG2 45146 9.75 111 2 6%
gi|148377751
MAG_4890
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Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus
ABC transporter. ATP-binding protein M. agalactiae PG2 68597 9.25 106 1 2%
gi|148377862
MAG_5990
ABC transporter permease protein M. agalactiae PG2 39653 9.72 94 2 6%
gi|148377768
MAG_5060
Cation-transporting P-type ATPase M. agalactiae PG2 100888 6.32 88 4 4%
gi|148377722
MAG_4590
Sugar ABC transporter permease M. agalactiae PG2 74657 9.45 85 3 4%
gi|148377283
MAG_0150
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 83 1 1%
gi|148377767
MAG_5050
Hypothetical protein MAG_2680 M. agalactiae PG2 55645 4.72 79 1 2%
gi|148377534
MAG_2680
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 78 2 6%
gi|148377385
MAG_1180
ABC transporter. permease protein M. agalactiae PG2 71089 8.87 66 1 1%
gi|148377723
MAG_4600
Preprotein translocase subunit SecY M. agalactiae PG2 54823 9.7 62 1 2%
gi|148377788
MAG_5260
Putative inner membrane protein 
translocase component YidC
M. agalactiae PG2 83003 9.48 51 3 3%
gi|148377328
MAG_0590
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 50 1 3%
gi|148377361
MAG_0930
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 45 2 3%
gi|148377364
MAG_0960
ABC transporter permease protein M. agalactiae PG2 37630 9.89 39 1 2%
gi|148377769
MAG_5070




M. pulmonis UAB 
CTIP
140043 8.49 30 1 0%
gi|15828853
MAG_3820
Protein-export membrane protein M. agalactiae PG2 89106 9.52 30 2 2%
gi|148377491
MAG_2250
ABC transporter. ATP-binding protein M. agalactiae PG2 67154 8.52 29 1 1%
gi|148377863
MAG_6000
3 Elongation factor Tu M. agalactiae PG2 43638 5.89 299 6 17%
gi|148377586
MAG_3200
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Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus
Sugar ABC transporter permease M. agalactiae PG2 74657 9.45 187 10 10%
gi|148377283
MAG_0150
ABC transporter permease protein M. agalactiae PG2 308764 8.86 178 5 1%
gi|148378006
MAG_7440
Putative inner membrane protein 
translocase component YidC
M. agalactiae PG2 83003 9.48 158 6 6%
gi|148377328
MAG_0590
Hypothetical protein MAG_0280 M. agalactiae PG2 75681 9.03 155 4 2%
gi|148377296
MAG_0280
Cation-transporting P-type ATPase M. agalactiae PG2 100888 6.32 154 4 4%
gi|148377722
MAG_4590
ABC transporter permease protein M. agalactiae PG2 39653 9.72 152 2 3%
gi|148377768
MAG_5060
Malate permease M. agalactiae PG2 45146 9.75 145 5 9%
gi|148377751
MAG_4890
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 141 4 9%
gi|148377752
MAG_4900
Protein-export membrane protein M. agalactiae PG2 89106 9.52 103 4 5%
gi|148377491
MAG_2250
ABC transporter. ATP-binding protein M. agalactiae PG2 68597 9.25 94 1 2%
gi|148377862
MAG_5990
Preprotein translocase subunit SecY M. agalactiae PG2 54823 9.7 91 2 3%
gi|148377788
MAG_5260
Prolipoprotein diacylglyceryl transferase M. agalactiae PG2 37843 9.3 87 1 3%
gi|148377358
MAG_0900
Cation-transporting P-ATPase M. agalactiae PG2 100451 8.6 82 2 2%
gi|148378004
MAG_7420
ABC transporter. ATP-binding protein M. agalactiae PG2 67154 8.52 81 2 3%
gi|148377863
MAG_6000
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 78 1 1%
gi|148377767
MAG_5050
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 72 7 7%
gi|148377364
MAG_0960
ABC transporter permease protein M. agalactiae PG2 37630 9.89 67 1 2%
gi|148377769
MAG_5070
Hypothetical protein MAG_2680 M. agalactiae PG2 55645 4.72 65 1 2%
gi|148377534
MAG_2680
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 64 2 3%
gi|148377362
MAG_0940
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Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 62 2 5%
gi|148377361
MAG_0930
Putative phosphoketolase M. agalactiae PG2 89860 6.07 56 3 3%
gi|148377390
MAG_1230
Oligopeptide ABC transporter system. 
permeaseprotein (OppC)
M. agalactiae PG2 47514 8.85 53 3 4%
gi|148377370
MAG_1020
DNA-directed RNA polymerase subunit 
beta'
M. agalactiae PG2 167709 6.47 50 1 <1%
gi|148377874
MAG_6110
ABC transporter. permease protein M. agalactiae PG2 71089 8.87 46 1 1%
gi|148377723
MAG_4600
P80. lipoprotein M. agalactiae PG2 81102 9.08 45 1 1%
gi|148377765
MAG_5030
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 44 2 6%
gi|148377385
MAG_1180




M. pulmonis UAB 
CTIP
140043 8.49 31 3 1%
gi|15828853
MYPU_3820
Hypothetical protein M. hyopneumoniae 3320 11.39 30 1 28%
gi|187610428
Hexosephosphate transport protein M. agalactiae PG2 54592 9.81 29 3 6%
gi|148377759
MAG_4970
4 ABC transporter permease protein M. agalactiae PG2 308764 8.86 265 14 4%
gi|148378006
MAG_7440
Putative phosphoketolase M. agalactiae PG2 89860 6.07 252 8 9%
gi|148377390
MAG_1230
Elongation factor Tu M. agalactiae PG2 43638 5.89 223 7 17%
gi|148377586
MAG_3200
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 176 4 7%
gi|148377767
MAG_5050
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 103 3 9%
gi|148377752
MAG_4900
DNA-directed RNA polymerase subunit 
beta
M. agalactiae PG2 135072 5.72 96 3 2%
gi|148377875
MAG_6120
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 95 2 3%
gi|148377364
MAG_0960
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Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus
Malate permease M. agalactiae PG2 45146 9.75 77 1 4%
gi|148377751
MAG_4890
Hypothetical protein MAG_2680 M. agalactiae PG2 55645 4.72 70 1 2%
gi|148377534
MAG_2680
Hypothetical protein MAG_0280 M. agalactiae PG2 75681 9.03 66 1 1%
gi|148377296
MAG_0280
P80. lipoprotein M. agalactiae PG2 81102 9.08 64 2 3%
gi|148377765
MAG_5030
Sugar ABC transporter permease M. agalactiae PG2 74657 9.45 63 3 4%
gi|148377283
MAG_0150
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 60 2 5%
gi|148377361
MAG_0930
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 51 2 3%
gi|148377362
MAG_0940
DNA-directed RNA polymerase subunit 
beta'
M. agalactiae PG2 167709 6.47 50 2 1%
gi|148377874
MAG_6110
Preprotein translocase subunit SecY M. agalactiae PG2 54823 9.7 44 1 2%
gi|148377788
MAG_5260




M. pulmonis UAB 
CTIP
139998 8.49 41 1 <1%
gi|15828853
MYPU_3820
Elongation factor G M. agalactiae PG2 77499 5.47 37 1 1%
gi|148377855
MAG_5920
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 35 1 3%
gi|148377385
MAG_1180
ABC transporter permease protein M. agalactiae PG2 39653 9.72 34 1 3%
gi|148377768
MAG_5060
Glycerol ABC transporter. ATP-binding 
protein
M. capricolum subsp. 
capricolum ATCC 
27343
47127 9.59 34 1 2%
gi|83319663
MCAP_0454
Putative inner membrane protein 
translocase component YidC
M. agalactiae PG2 83003 9.48 33 2 3%
gi|148377328
MAG_0590
Alanyl-tRNA synthetase M. agalactiae PG2 100239 5.37 29 1 1%
gi|148377682
MAG_4160
Hypothetical protein M.  hyopneumoniae ??? 27 1
gi|187610428
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5
DNA-directed RNA polymerase subunit 
beta'
M. agalactiae PG2 167709 6.47 1305 54 21%
gi|148377874
MAG_6110
P80. lipoprotein M. agalactiae PG2 81102 9.08 106 4 5%
gi|148377765
MAG_5030
Elongation factor Tu M. agalactiae PG2 43638 5.89 104 4 11%
gi|148377586
MAG_3200
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 97 2 3%
gi|148377362
MAG_0940
Hypothetical protein MAG_2680 M. agalactiae PG2 55645 4.72 76 1 2%
gi|148377534
MAG_2680
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 73 2 3%
gi|148377767
MAG_5050
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 67 4 7%
gi|148377361
MAG_0930
Sugar ABC transporter permease M. agalactiae PG2 74657 9.45 56 1 1%
gi|148377283
MAG_0150
Putative phosphoketolase M. agalactiae PG2 89860 6.07 53 2 2%
gi|148377390
MAG_1230
Preprotein translocase subunit SecY M. agalactiae PG2 54823 9.7 42 2 3%
gi|148377788
MAG_5260
Malate permease M. agalactiae PG2 45146 9.75 41 2 6%
gi|148377751
MAG_4890
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 36 2 5%
gi|148377385
MAG_1180
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 27 2 3%
gi|148377364
MAG_0960




DNA-directed RNA polymerase subunit 
beta
M. agalactiae PG2 135072 5.13 1663 70 28%
gi|148377875
MAG_6120
Elongation factor Tu M. agalactiae PG2 43638 5.89 119 2 6%
gi|148377586
MAG_3200
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 117 2 3%
gi|148377767
MAG_5050
DNA-directed RNA polymerase subunit 
beta'
M. agalactiae PG2 167709 6.47 102 4 2%
gi|148377874
MAG_6110
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Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 88 2 3%
gi|148377364
MAG_0960
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 83 3 3%
gi|148377362
MAG_0940
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 68 1 2%
gi|148377752
MAG_4900
P80. lipoprotein M. agalactiae PG2 81102 9.08 64 1 1%
gi|148377765
MAG_5030
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 57 2 5%
gi|148377361
MAG_0930
Preprotein translocase subunit SecY M. agalactiae PG2 54823 9.7 38 1 2%
gi|148377788
MAG_5260
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 34 1 2%
gi|148377385
MAG_1180
9 Hypothetical protein MAG_1000 M. agalactiae PG2 109727 8.66 1984 76 38%
gi|148377368
MAG_1000
Hypothetical protein MAG_2680 M. agalactiae PG2 55645 4.72 444 14 32%
gi|148377534
MAG_2680
Alanyl-tRNA synthetase M. agalactiae PG2 100239 5.37 165 3 4%
gi|148377682
MAG_4160
Elongation factor Tu M. agalactiae PG2 43638 5.89 161 4 8%
gi|148377586
MAG_3200
Isoleucyl-tRNA synthetase M. agalactiae PG2 103127 6.19 134 7 6%
gi|148377486
MAG_2200
Preprotein translocase subunit SecA M. agalactiae PG2 96419 5.16 72 2 2%
gi|148377539
MAG_2730
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 62 1 3%
gi|148377362
MAG_0940
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 61 2 5%
gi|148377361
MAG_0930
Oligopeptide ABC transporter. substrate-
bindingprotein (OppA). lipoprotein
M. agalactiae PG2 113019 6.24 55 1 1%
gi|148377306
MAG_0380
DNA gyrase subunit A M. agalactiae PG2 103247 5.33 43 1 1%
gi|148377826
MAG_5630
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 43 1 3%
gi|148377385
MAG_1180
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Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus
Hydrolase (HAD family)
M. capricolum subsp.  
capricolum ATCC 
27343
5768 5.25 37 1 21%
gi|963067
10 Hypothetical protein MAG_1000 M. agalactiae PG2 109727 8.66 221 10 9%
gi|148377368
MAG_1000
Preprotein translocase subunit SecA M. agalactiae PG2 96419 5.16 158 6 7%
gi|148377539
MAG_2730
Alanyl-tRNA synthetase M. agalactiae PG2 100239 5.37 147 3 3%
gi|148377682
MAG_4160
Modification (methylase) protein of type 
irestriction-modification system HsdM
M. agalactiae PG2 103753 5.07 111 4 5%
gi|148377836
MAG_5730
Modification (methylase) protein of type 
irestriction-modification system
M. agalactiae PG2 103659 5.02 111 4 5%
gi|148377828
MAG_5650
Putative phosphoketolase M. agalactiae PG2 89860 6.07 92 1 2%
gi|148377390
MAG_1230
Valyl-tRNA synthetase M. agalactiae PG2 97424 8.78 87 2 2%
gi|148377404
MAG_1370
Elongation factor Tu M. agalactiae PG2 43638 5.89 84 1 3%
gi|148377586
MAG_3200
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 58 1 1%
gi|148377767
MAG_5050
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 54 1 3%
gi|148377361
MAG_0930
Glycerol ABC transporter. ATP-binding 
protein
M. capricolum subsp. 
capricolum ATCC 
27343
47127 9.59 37 1 2%
gi|83319663
MCAP_0454
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 31 1 1%
gi|148377364
MAG_0960
11 Putative phosphoketolase M. agalactiae PG2 89860 6.07 1733 48 31%
gi|148377390
MAG_1230
P80. lipoprotein M. agalactiae PG2 81102 9.08 292 8 9%
gi|148377765
MAG_5030
Oligopeptide ABC transporter. ATP-
bindingprotein (OppF)
M. agalactiae PG2 93878 8.99 226 11 15%
gi|148377372
MAG_1040
Elongation factor Tu M. agalactiae PG2 43638 5.89 211 4 9% gi|148377586 MAG_3200
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ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 112 2 3%
gi|148377767
MAG_5050
Leucyl-tRNA synthetase (leucine-tRNA 
ligase)
M. agalactiae PG2 91191 7.51 94 5 5%
gi|148377630
MAG_3640
Elongation factor G M. agalactiae PG2 77499 5.47 85 3 3%
gi|148377855
MAG_5920
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 81 3 7%
gi|148377361
MAG_0930
Endopeptidase O M. agalactiae PG2 75007 8.5 73 1 1%
gi|148377634
MAG_3680
Ribonuclease R M. agalactiae PG2 84293 6.36 58 1 1%
gi|148377474
MAG_2080
Hypothetical protein MAG_1000 M. agalactiae PG2 109727 8.66 57 1 1%
gi|148377368
MAG_1000
Hypothetical protein MAG_6230 M. agalactiae PG2 82041 6.18 45 2 2%
gi|148377886
MAG_6230
Glycerol ABC transporter. ATP-binding 
protein
M. capricolum subsp. 
capricolum ATCC 
27343
47127 9.59 38 1 2%
gi|83319663
MCAP_0454
12 P80. lipoprotein M. agalactiae PG2 81102 9.08 1144 49 30%
gi|148377765
MAG_5030
Putative phosphoketolase M. agalactiae PG2 89860 6.07 610 17 12%
gi|148377390
MAG_1230
Hypothetical protein MAG_6230 M. agalactiae PG2 82041 6.18 339 8 14%
gi|148377886
MAG_6230
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 135 3 6%
gi|148377767
MAG_5050
Hypothetical protein MAG_1970 M. agalactiae PG2 82243 9.03 133 3 5%
gi|148377463
MAG_1970
ClpB M. agalactiae PG2 82234 5.98 126 2 3%
gi|148377887
MAG_6240
Elongation factor G M. agalactiae PG2 77499 5.47 125 4 5%
gi|148377855
MAG_5920
Elongation factor Tu M. agalactiae PG2 43638 5.89 122 3 8%
gi|148377586
MAG_3200
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Endopeptidase O M. agalactiae PG2 75007 8.5 67 1 1%
gi|148377634
MAG_3680
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 53 1 3%
gi|148377361
MAG_0930
Glycerol ABC transporter. ATP-binding 
protein
M. capricolum subsp. 
capricolum ATCC 
27343
47127 9.59 42 1 2%
gi|83319663
MCAP_0454
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 42 1 3%
gi|148377362
MAG_0940
leucyl-tRNA synthetase (leucine-tRNA 
ligase)
M. agalactiae PG2 91191 7.51 29 2 2% gi|148377630 MAG_3640
13 P80. lipoprotein M. agalactiae PG2 81102 9.08 1913 51 48%
gi|148377765
MAG_5030
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 600 18 23%
gi|148377767
MAG_5050
Hypothetical protein MAG_1970 M. agalactiae PG2 82243 9.03 424 15 18%
gi|148377463
MAG_1970
ClpB M. agalactiae PG2 82234 5.98 101 4 6%
gi|148377887
MAG_6240
Cell division protein ftsH-like protein M. agalactiae PG2 74857 5.94 101 3 6%
gi|148378007
MAG_7450
DNA gyrase subunit B M. agalactiae PG2 73507 5.85 92 2 2%
gi|148377999
MAG_7370
Hypothetical protein MAG_6230 M. agalactiae PG2 82041 6.18 84 1 2%
gi|148377886
MAG_6230
Elongation factor G M. agalactiae PG2 77499 5.47 59 1 1%
gi|148377855
MAG_5920
Glycerol ABC transporter. ATP-binding 
protein
M. capricolum subsp. 
capricolum ATCC 
27343
47127 9.59 47 1 2%
gi|83319663
MCAP_0454
Endopeptidase O M. agalactiae PG2 75007 8.5 47 4 5%
gi|148377634
MAG_3680
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 44 1 3%
gi|148377361
MAG_0930
Putative phosphoketolase M. agalactiae PG2 89860 6.07 43 1 1%
gi|148377390
MAG_1230
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Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 43 1 1%
gi|148377364
MAG_0960
14 5'nucleotidase M. agalactiae PG2 76195 8.36 1167 35 34%
gi|148377854
MAG_5910
P80. lipoprotein M. agalactiae PG2 81102 9.08 934 29 33%
gi|148377765
MAG_5030
Putative inner membrane protein 
translocase component YidC
M. agalactiae PG2 83003 9.48 617 14 21%
gi|148377328
MAG_0590
Molecular chaperone DnaK M. agalactiae PG2 65263 4.95 459 11 16%
gi|148377413
MAG_1460
Endopeptidase O M. agalactiae PG2 75007 8.5 394 12 15%
gi|148377634
MAG_3680
ABC transporter ATP-binding protein M. agalactiae PG2 80105 9.01 310 9 14%
gi|148377767
MAG_5050
Cell division protein ftsH-like protein M. agalactiae PG2 74857 5.94 204 8 13%
gi|148378007
MAG_7450
Excinuclease ABC subunit B M. agalactiae PG2 77404 5.78 94 3 4%
gi|148377644
MAG_3780
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 58 2 5%
gi|148377361
MAG_0930
Hypothetical protein MAG_1970 M. agalactiae PG2 82243 9.03 54 1 1%
gi|148377463
MAG_1970
DNA gyrase subunit B M. agalactiae PG2 73507 5.85 52 1 1%
gi|148377999
MAG_7370
DNA polymerase III subunit gamma and 
tau
M. agalactiae PG2 70644 5.25 51 2 3%
gi|148377949
MAG_6870
Hypothetical protein MAG_4720 M. agalactiae PG2 86074 8.82 47 2 2%
gi|148377735
MAG_4720
Glycerol ABC transporter. ATP-binding 
protein
M. capricolum subsp. 
capricolum ATCC 
27343
47127 9.59 44 2 6%
gi|83319663
MCAP_0454




Putative inner membrane protein 
translocase component YidC
M. agalactiae PG2 83003 9.48 768 23 23%
gi|148377328
MAG_0590
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5'nucleotidase M. agalactiae PG2 76195 8.36 508 17 17%
gi|148377854
MAG_5910
P80. lipoprotein M. agalactiae PG2 81102 9.08 421 13 19%
gi|148377765
MAG_5030
Hypothetical protein MAG_6520 M. agalactiae PG2 70087 8.58 376 12 17%
gi|148377915
MAG_6520
Hypothetical protein MAG_1210 M. agalactiae PG2 70044 5.71 234 8 10%
gi|148377388
MAG_1210
ABC transporter ATP-binding protein M. agalactiae PG2 61006 5.24 200 9 11%
gi|148377859
MAG_5960
DNA ligase M. agalactiae PG2 74509 6.12 106 3 5%
gi|148377548
MAG_2820
Endopeptidase O M. agalactiae PG2 75007 8.5 79 3 2%
gi|148377634
MAG_3680
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 43 4 5%
gi|148377364
MAG_0960
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 42 1 3%
gi|148377361
MAG_0930
Hypothetical protein MAG_2360 M. agalactiae PG2 75426 6.19 33 1 1%
gi|148377502
MAG_2360
Topoisomerase IV subunit B M. agalactiae PG2 72252 8.07 31 2 2%
gi|148377448
MAG_1820
16 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 1512 63 32%
gi|148377488
MAG_2220
ABC transporter ATP-binding protein M. agalactiae PG2 61006 5.24 394 18 19%
gi|148377859
MAG_5960
Hypothetical protein MAG_6520 M. agalactiae PG2 70087 8.58 365 13 13%
gi|148377915
MAG_6520
Threonyl-tRNA synthetase M. agalactiae PG2 67728 8.77 146 3 3%
gi|148377610
MAG_3440
Putative inner membrane protein 
translocase component YidC
M. agalactiae PG2 83003 9.48 101 3 5%
gi|148377328
MAG_0590
P80. lipoprotein M. agalactiae PG2 81102 9.08 97 4 5%
gi|148377765
MAG_5030
Type III restriction-modification system: 
methylase
M. agalactiae PG2 66381 6.17 96 7 8%
gi|148377420
MAG_1530
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Trigger factor M. agalactiae PG2 56779 5.15 86 6 9%
gi|148377421
MAG_1540
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 58 2 5%
gi|148377361
MAG_0930
Dihydrolipoamide dehydrogenase (E3 
component of pyruvate complex)
M. agalactiae PG2 58917 6.36 43 2 3%
gi|148377364
MAG_0960
Hypothetical protein MAG_3240 M. agalactiae PG2 72359 8.02 36 2 3%
gi|148377590
MAG_3240
Hypothetical protein MAG_1210 M. agalactiae PG2 70044 5.71 36 2 2%
gi|148377388
MAG_1210
Protein-export membrane protein M. agalactiae PG2 89106 9.52 34 1 1%
gi|148377491
MAG_2250
Hypothetical protein MAG_2340 M. agalactiae PG2 66023 7.56 28 5 1%
gi|148377500
MAG_2340
Hypothetical protein MAG_4410 M. agalactiae PG2 60649 5.12 26 1 3%
gi|148377704
MAG_4410
17 Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 300 12 13%
gi|148377488
MAG_2220
Threonyl-tRNA synthetase M. agalactiae PG2 67728 8.77 135 8 8%
gi|148377610
MAG_3440
Hypothetical protein MAG_0280 M. agalactiae PG2 75681 9.03 55 1 1%
gi|148377296
MAG_0280
P80. lipoprotein M. agalactiae PG2 81102 9.08 49 2 3%
gi|148377765
MAG_5030
Type III restriction-modification system: 
methylase
M. agalactiae PG2 66381 6.17 40 1 1%
gi|148377420
MAG_1530




ABC transporter. ATP-binding protein. 
P59
M. agalactiae PG2 58997 6.43 852 29 18%
gi|148377282
MAG_0140
F0F1 ATP synthase subunit alpha M. agalactiae PG2 58096 5.95 126 3 7%
gi|148377620
MAG_3540
Phosphoglyceromutase M. agalactiae PG2 55761 5.87 126 2 2%
gi|148377951
MAG_6890
CTP synthetase M. agalactiae PG2 60669 7.65 122 4 7% gi|148377485 MAG_2190
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Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 84 4 7%
gi|148377488
MAG_2220
Pyruvate kinase M. agalactiae PG2 53469 5.81 72 2 3%
gi|148377411
MAG_1440
Lysyl-tRNA synthetase M. agalactiae PG2 56530 5.56 53 1 2%
gi|148377884
MAG_6210
Spermidine/putrescine ABC transporter 
ATP-binding protein
M. agalactiae PG2 54920 6.15 53 1 1%
gi|148377392
MAG_1250
Preprotein translocase subunit SecY M. agalactiae PG2 54823 9.7 48 1 2%
gi|148377788
MAG_5260
P80. lipoprotein M. agalactiae PG2 81102 9.08 38 2 3%
gi|148377765
MAG_5030
ABC transporter. ATP-binding protein M. agalactiae PG2 67154 8.52 37 2 3%
gi|148377863
MAG_6000
Elongation factor Tu M. agalactiae PG2 43638 5.89 31 1 2%
gi|148377586
MAG_3200
Type III restriction-modification system: 
methylase
M. agalactiae PG2 66381 6.17 29 1 1%
gi|148377420
MAG_1530
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 25 1 2%
gi|148377385
MAG_1180
19 Pyruvate kinase M. agalactiae PG2 53469 5.81 751 24 35%
gi|148377411
MAG_1440
Lipoprotein MAG_5080 M. agalactiae PG2 59415 6.77 608 30 27%
gi|148377770
MAG_5080
Lysyl-tRNA synthetase M. agalactiae PG2 56530 5.56 363 13 25%
gi|148377884
MAG_6210
Hypothetical protein MAG_1430 M. agalactiae PG2 56379 8.52 330 8 15%
gi|148377410
MAG_1430
ABC transporter. ATP-binding protein M. agalactiae PG2 67154 8.52 241 4 8%
gi|148377863
MAG_6000
Glutamyl-tRNA synthetase M. agalactiae PG2 53870 6.08 239 9 17%
gi|148377841
MAG_5780
Methionyl-tRNA synthetase M. agalactiae PG2 60263 5.89 207 3 7%
gi|148377472
MAG_2060
Prolyl-tRNA synthetase M. agalactiae PG2 55488 9.24 198 5 11% gi|148377386 MAG_1190
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ABC transporter. ATP-binding protein. 
P59
M. agalactiae PG2 58997 6.43 185 8 16%
gi|148377282
MAG_0140
Elongation factor Tu M. agalactiae PG2 43638 5.89 97 3 6%
gi|148377586
MAG_3200
Hypothetical protein MAG_2220 M. agalactiae PG2 69573 8.78 89 3 5%
gi|148377488
MAG_2220
Phosphoglyceromutase M. agalactiae PG2 55761 5.87 89 1 2%
gi|148377951
MAG_6890
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 56 1 3%
gi|148377361
MAG_0930
Spermidine/putrescine ABC transporter 
ATP-binding protein
M. agalactiae PG2 54920 6.15 53 1 1%
gi|148377392
MAG_1250
20 Pyruvate kinase M. agalactiae PG2 53469 5.81 243 11 20%
gi|148377411
MAG_1440
Glycerol kinase M. agalactiae PG2 56853 5.95 223 7 9%
gi|148377710
MAG_4470
Hypothetical protein MAG_1430 M. agalactiae PG2 56379 8.52 153 2 5%
gi|148377410
MAG_1430
Aminopeptidase (leucine aminopeptidase) M. agalactiae PG2 50393 5.63 91 2 2%
gi|148377964
MAG_7020
Elongation factor Tu M. agalactiae PG2 43638 5.89 80 2 5%
gi|148377586
MAG_3200
Lysyl-tRNA synthetase M. agalactiae PG2 56530 5.56 80 4 5%
gi|148377884
MAG_6210
Replicative DNA helicase M. agalactiae PG2 56206 6.66 71 1 1%
gi|148377504
MAG_2380
Glutamyl-tRNA synthetase M. agalactiae PG2 53870 6.08 48 1 1%
gi|148377841
MAG_5780
P80. lipoprotein M. agalactiae PG2 81102 9.08 46 2 3%
gi|148377765
MAG_5030
Lipoprotein. MAG_5080 M. agalactiae PG2 59415 6.77 45 4 6%
gi|148377770
MAG_5080
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 33 1 2%
gi|148377385
MAG_1180
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21 Hypothetical protein MAG_4460 M. agalactiae PG2 52483 8.7 658 30 26%
gi|148377709
MAG_4460
P48. lipoprotein M. agalactiae PG2 51232 8.39 481 17 30%
gi|148377280
MAG_0120
F0F1 ATP synthase subunit beta M. agalactiae PG2 53330 5.28 371 9 17%
gi|148377622
MAG_3560
Aminopeptidase (leucine aminopeptidase) M. agalactiae PG2 50393 5.63 367 13 21%
gi|148377964
MAG_7020
Glycerol kinase M. agalactiae PG2 56853 5.95 238 6 11%
gi|148377710
MAG_4470
NADH oxidase (NOXASE) M. agalactiae PG2 49980 6.09 235 9 17%
gi|148377529
MAG_2630
Variable surface lipoprotein V M. agalactiae PG2 37362 9.25 133 6 12%
gi|148377967
MAG_7050
GTPase ObgE M. agalactiae PG2 46867 5.66 116 4 7%
gi|148377771
MAG_5090
Signal recognition particle protein M. agalactiae PG2 50358 9.17 95 2 4%
gi|148377845
MAG_5820
DNA recombination protein M. agalactiae PG2 55552 6.27 80 3 7%
gi|148377514
MAG_2480
P80. lipoprotein M. agalactiae PG2 81102 9.08 54 2 2%
gi|148377765
MAG_5030
Hypothetical protein MAG_1430 M. agalactiae PG2 56379 8.52 54 1 2%
gi|148377410
MAG_1430
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 50 1 3%
gi|148377361
MAG_0930
Glycyl-tRNA synthetase M. agalactiae PG2 53051 6.02 44 1 2%
gi|148377533
MAG_2670
Hypothetical protein MAG_1670 M. agalactiae PG2 53061 8.58 36 2 4%
gi|148377434
MAG_1670
Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 30 1 3%
gi|148377389
MAG_1220
Glutamyl-tRNA synthetase M. agalactiae PG2 53870 6.08 26 1 1%
gi|148377841
MAG_5780
22 P48. lipoprotein M. agalactiae PG2 51232 8.39 1501 47 57%
gi|148377280
MAG_0120
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Lipoprotein. MAG_1980 M. agalactiae PG2 53788 8.98 176 8 20%
gi|148377464
MAG_1980
Mg2+ transport protein (MGTE) M. agalactiae PG2 54236 4.74 149 3 7%
gi|148377573
MAG_3070
Hypothetical protein MAG_4460 M. agalactiae PG2 52483 8.7 138 6 13%
gi|148377709
MAG_4460
NADH oxidase (NOXASE) M. agalactiae PG2 49980 6.09 112 3 9%
gi|148377529
MAG_2630
Aminopeptidase (leucine aminopeptidase) M. agalactiae PG2 50393 5.63 83 1 2%
gi|148377964
MAG_7020
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 72 2 5%
gi|148377385
MAG_1180
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 52 1 3%
gi|148377361
MAG_0930
P80. lipoprotein M. agalactiae PG2 81102 9.08 47 3 3%
gi|148377765
MAG_5030
Signal recognition particle protein M. agalactiae PG2 50358 9.17 43 1 2%
gi|148377845
MAG_5820
PhosphoPyruvate hydratase M. agalactiae PG2 49710 5.43 32 2 3%
gi|148377585
MAG_3190
Seryl-tRNA synthetase M. agalactiae PG2 48281 5.62 32 2 4%
gi|148377324
MAG_0560
23 Elongation factor Tu M. agalactiae PG2 43638 5.89 1003 23 33%
gi|148377586
MAG_3200
P48. lipoprotein M. agalactiae PG2 51232 8.39 997 28 49%
gi|148377280
MAG_0120
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 407 15 28%
gi|148377385
MAG_1180
Phosphopentomutase M. agalactiae PG2 43893 5.48 336 7 18%
gi|148377546
MAG_2800
Alkylphosphonate ABC transporter 
substrate-binding protein
M. agalactiae PG2 49744 6.99 272 6 12%
gi|148377535
MAG_2690
Phosphoglycerate kinase M. agalactiae PG2 42781 5.79 139 4 10%
gi|148377849
MAG_5860
Hypothetical protein MAG_1810 M. agalactiae PG2 52991 9.16 134 2 3%
gi|148377447
MAG_1810
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Amidase M. agalactiae PG2 48487 6.29 121 1 3%
gi|148377979
MAG_7170
Lipoprotein. MAG_1980 M. agalactiae PG2 53788 8.98 67 2 4%
gi|148377464
MAG_1980
Hypothetical protein MAG_4460 M. agalactiae PG2 52483 8.7 63 1 2%
gi|148377709
MAG_4460
P80. lipoprotein M. agalactiae PG2 81102 9.08 49 3 4%
gi|148377765
MAG_5030
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 42 1 3%
gi|148377361
MAG_0930
Asparaginyl-tRNA synthetase M. agalactiae PG2 51629 7.25 33 2 4%
gi|148377568
MAG_3020
24 Elongation factor Tu M. agalactiae PG2 43638 5.89 2042 45 46%
gi|148377586
MAG_3200
Phosphoglycerate kinase M. agalactiae PG2 42781 5.79 441 19 25%
gi|148377849
MAG_5860
Hypothetical protein MAG_5040 M. agalactiae PG2 44828 8.46 401 14 26%
gi|148377766
MAG_5040
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 168 9 16%
gi|148377385
MAG_1180
Phosphopentomutase M. agalactiae PG2 43893 5.48 111 4 7%
gi|148377546
MAG_2800
Alkylphosphonate ABC transporter 
substrate-binding protein
M. agalactiae PG2 49744 6.99 106 2 6%
gi|148377535
MAG_2690
P48. lipoprotein M. agalactiae PG2 51232 8.39 95 2 4%
gi|148377280
MAG_0120
Tyrosyl-tRNA synthetase 1 M. agalactiae PG2 46669 7.59 54 2 5%
gi|148377992
MAG_7300
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 43 1 3%
gi|148377361
MAG_0930
Hypothetical protein MAG_2810 M. agalactiae PG2 48061 9.19 40 2 3%
gi|148377547
MAG_2810
DNA-directed RNA polymerase subunit 
alpha
M. agalactiae PG2 37453 5.98 36 2 5%
gi|148377782
MAG_5200
25 Elongation factor Tu M. agalactiae PG2 43638 5.89 1296 27 39% gi|148377586 MAG_3200
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Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 581 21 31%
gi|148377361
MAG_0930
Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 502 16 33%
gi|148377970
MAG_7080
Hypothetical protein MAG_5040 M. agalactiae PG2 44828 8.46 475 16 33%
gi|148377766
MAG_5040
DNA-directed RNA polymerase subunit 
alpha
M. agalactiae PG2 37453 5.98 156 5 16%
gi|148377782
MAG_5200
XAA-Pro aminopeptidase M. agalactiae PG2 40001 5.88 111 4 11%
gi|148377385
MAG_1180
Alcohol dehydrogenase M. agalactiae PG2 37640 6.31 111 3 10%
gi|148377540
MAG_2740
Hypothetical protein MAG_6740 M. agalactiae PG2 40257 5.55 96 2 3%
gi|148377936
MAG_6740
Alcohol dehydrogenase M. agalactiae PG2 38157 6.28 92 3 8%
gi|148377697
MAG_4340
Phosphoglycerate kinase M. agalactiae PG2 42781 5.79 86 5 12%
gi|148377849
MAG_5860
Alkylphosphonate ABC transporter 
substrate-binding protein
M. agalactiae PG2 49744 6.99 71 1 3%
gi|148377535
MAG_2690
Phosphopentomutase M. agalactiae PG2 43893 5.48 59 2 5%
gi|148377546
MAG_2800
Acetate kinase M. agalactiae PG2 44283 6.24 55 1 3%
gi|148377407
MAG_1400
ABC transporter ATP-binding protein M. agalactiae PG2 40400 9.22 43 1 3%
gi|148378005
MAG_7430
Hypothetical protein MAG_2810 M. agalactiae PG2 48061 9.19 39 1 1%
gi|148377547
MAG_2810
Variable surface lipoprotein U M. agalactiae PG2 25529 8.62 33 1 3%
gi|148377971
MAG_7090
26 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 1004 28 32%
gi|148377970
MAG_7080
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 500 14 37%
gi|148377361
MAG_0930
D-lactate dehydrogenase M. agalactiae PG2 37021 6.11 424 11 31% gi|148377416 MAG_1490
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Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus
P40. lipoprotein M. agalactiae PG2 39951 8.19 380 9 25%
gi|148377507
MAG_2410
Elongation factor Tu M. agalactiae PG2 43638 5.89 366 10 28%
gi|148377586
MAG_3200
30S ribosomal protein S7 M. agalactiae PG2 35450 9.51 303 9 39%
gi|148377525
MAG_2590
Alcohol dehydrogenase M. agalactiae PG2 37640 6.31 115 3 15%
gi|148377540
MAG_2740










M. agalactiae PG2 37025 8.14 29 2 5%
gi|148377703
MAG_4400
27 D-lactate dehydrogenase M. agalactiae PG2 37021 6.11 649 15 47%
gi|148377416
MAG_1490
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 634 16 40%
gi|148377362
MAG_0940





M. agalactiae PG2 36871 6.72 428 8 27%
gi|148377323
MAG_0550
Hypothetical protein MAG_4450 M. agalactiae PG2 37490 5.32 258 4 11%
gi|148377708
MAG_4450
P40. lipoprotein M. agalactiae PG2 39951 8.19 243 6 17%
gi|148377507
MAG_2410
Variable surface lipoprotein W M. agalactiae PG2 35472 9.54 226 4 7%
gi|148377968
MAG_7060
Phosphotransacetylase M. agalactiae PG2 34447 6.11 208 4 12%
gi|148377406
MAG_1390
30S ribosomal protein S7 M. agalactiae PG2 35450 9.51 155 6 18%
gi|148377525
MAG_2590
Lipoprotein. MAG_2350 M. agalactiae PG2 40383 8.61 131 4 13%
gi|148377501
MAG_2350
Hypothetical protein MAG_1780 M. agalactiae PG2 37986 6.06 113 4 15% gi|148377444 MAG_1780
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Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 98 2 7%
gi|148377361
MAG_0930
Elongation factor Tu M. agalactiae PG2 43638 5.89 77 1 3%
gi|148377586
MAG_3200
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 69 1 3%
gi|148377752
MAG_4900
Lipoate-protein ligase A M. agalactiae PG2 37286 6.42 60 2 5%
gi|148377329
MAG_0600




Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 950 29 25%
gi|148377362
MAG_0940
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 567 21 35%
gi|148377752
MAG_4900
Elongation factor Ts (EF-Ts) M. agalactiae PG2 32763 5.18 539 8 24%
gi|148377526
MAG_2600
Elongation factor Tu M. agalactiae PG2 43638 5.89 232 5 14%
gi|148377586
MAG_3200
Hypothetical protein MAG_7400 M. agalactiae PG2 37245 9.18 170 5 14%
gi|148378002
MAG_7400
Phosphotransacetylase M. agalactiae PG2 34447 6.11 152 4 10%
gi|148377406
MAG_1390





M. agalactiae PG2 36871 6.72 128 3 11%
gi|148377323
MAG_0550
50S ribosomal protein L4 M. agalactiae PG2 32406 10.26 126 6 18%
gi|148377808
MAG_5450
D-lactate dehydrogenase M. agalactiae PG2 37021 6.11 92 2 6%
gi|148377416
MAG_1490
Glycerol-3-phosphate dehydrogenase M. agalactiae PG2 36931 7.01 85 5 11%
gi|148377318
MAG_0500
Hypothetical protein MAG_4440 M. agalactiae PG2 36488 5.87 85 4 7%
gi|148377707
MAG_4440
Hypothetical protein MAG_4450 M. agalactiae PG2 37490 5.32 85 2 6% gi|148377708 MAG_4450
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50S ribosomal protein L2 M. agalactiae PG2 30773 10.63 72 4 9%
gi|148377806
MAG_5430
Hypothetical protein MAG_1450 M. agalactiae PG2 35463 9.15 71 4 11%
gi|148377412
MAG_1450
5'nucleotidase M. agalactiae PG2 76195 8.36 60 1 1%
gi|148377854
MAG_5910
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 59 2 5%
gi|148377361
MAG_0930
Variable surface lipoprotein A M. agalactiae PG2 24769 8.33 56 3 14%
gi|148377969
MAG_7070
Lipoprotein. MAG_2430 M. agalactiae PG2 33862 8.29 52 2 7%
gi|148377509
MAG_2430
30S ribosomal protein S7 M. agalactiae PG2 35450 9.51 46 2 2%
gi|148377525
MAG_2590
Malate permease M. agalactiae PG2 45146 9.75 42 1 2%
gi|148377751
MAG_4890
P30. lipoprotein M. agalactiae PG2 29213 9.29 42 1 4%
gi|148377613
MAG_3470
Lipoate-protein ligase A M. agalactiae PG2 37286 6.42 27 2 5%
gi|148377329
MAG_0600
29 Lipoprotein. MAG_2430 M. agalactiae PG2 33862 8.29 1289 31 54%
gi|148377509
MAG_2430
Elongation factor Ts (EF-Ts) M. agalactiae PG2 32763 5.18 353 8 32%
gi|148377526
MAG_2600
Variable surface lipoprotein D (Variable 
surface lipopr. Z)
M. agalactiae PG2 36608 8.52 240 8 15%
gi|148377972
MAG_7100
Lipoprotein. MAG_1050 M. agalactiae PG2 37025 9.26 224 4 16%
gi|148377373
MAG_1050
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 220 7 20%
gi|148377362
MAG_0940
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 219 7 23%
gi|148377752
MAG_4900
Malate permease M. agalactiae PG2 45146 9.75 216 3 6%
gi|148377751
MAG_4890
50S ribosomal protein L3 M. agalactiae PG2 28793 9.75 194 10 34% gi|148377809 MAG_5460
Dott.ssa Carla Cacciotto, Characterization of Mycoplasma agalactiae membrane proteome.
Tesi di Dottorato in Scienze Biomolecolari e Biotecnologiche, Università degli Studi di Sassari.
Band Protein Organism Mw (Da) pI Score Queries Coverage Acc. No. Locus





M. agalactiae PG2 35626 6.75 110 2 7%
gi|148377754
MAG_4920
Elongation factor Tu M. agalactiae PG2 43638 5.89 97 2 6%
gi|148377586
MAG_3200
Hypothetical protein MAG_0250 M. agalactiae PG2 32658 6.55 67 1 3%
gi|148377293
MAG_0250
Hypothetical protein MAG_1450 M. agalactiae PG2 35463 9.15 58 1 3%
gi|148377412
MAG_1450
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 37 1 3%
gi|148377361
MAG_0930
50S ribosomal protein L1 M. agalactiae PG2 24955 9.68 34 2 9%
gi|148377349
MAG_0810
50S ribosomal protein L4 M. agalactiae PG2 32406 10.26 30 2 8%
gi|148377808
MAG_5450
30 Lipoprotein. MAG_2430 M. agalactiae PG2 33862 8.29 1053 35 42%
gi|148377509
MAG_2430
50S ribosomal protein L1 M. agalactiae PG2 24955 9.68 354 15 30%
gi|148377349
MAG_0810
50S ribosomal protein L3 M. agalactiae PG2 28793 9.75 256 10 20%
gi|148377809
MAG_5460
Variable surface lipoprotein D M. agalactiae PG2 36608 8.52 227 16 19%
gi|148377972
MAG_7100
50S ribosomal protein L2 M. agalactiae PG2 30773 10.63 174 12 12%
gi|148377806
MAG_5430
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 149 3 6%
gi|148377752
MAG_4900
Elongation factor Ts (EF-Ts) M. agalactiae PG2 32763 5.18 62 1 5%
gi|148377526
MAG_2600
Cobalt transporter ATP-binding subunit M. agalactiae PG2 29354 6.03 51 1 3%
gi|148377780
MAG_5180
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 51 1 3%
gi|148377362
MAG_0940
Lipoprotein. MAG_6200 M. agalactiae PG2 26952 9.22 42 2 9% gi|148377883 MAG_6200
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Methionyl-tRNA formyltransferase M. agalactiae PG2 31227 9.21 34 1 2%
gi|148377891
MAG_6280
F0F1 ATP synthase subunit gamma M. agalactiae PG2 32874 9.01 31 1 2%
gi|148377621
MAG_3550
31 Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 323 13 34%
gi|148377389
MAG_1220
Lipoprotein. MAG_6200 M. agalactiae PG2 26952 9.22 299 4 9%
gi|148377883
MAG_6200
50S ribosomal protein L1 M. agalactiae PG2 24955 9.68 201 9 26%
gi|148377349
MAG_0810
Uridylate kinase M. agalactiae PG2 26309 6.64 154 3 16%
gi|148377314
MAG_0460
30S ribosomal protein S5 M. agalactiae PG2 25266 10.25 151 10 28%
gi|148377792
MAG_5300
Lipoprotein. MAG_2430 M. agalactiae PG2 33862 8.29 120 5 13%
gi|148377509
MAG_2430
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 101 4 9%
gi|148377752
MAG_4900
30S ribosomal protein S68 M. agalactiae PG2 12097 10.2 86 1 15%
gi|148377544
MAG_2780
ABC transporter permease protein M. agalactiae PG2 39653 9.72 73 1 3%
gi|148377768
MAG_5060
Triosephosphate isomerase M. agalactiae PG2 29382 6.18 62 1 5%
gi|148377776
MAG_5140
HAD superfamily hydrolase M. agalactiae PG2 31183 9.45 57 1 3%
gi|148377295
MAG_0270
Variable surface lipoprotein D M. agalactiae PG2 36608 8.52 56 3 9%
gi|148377972
MAG_7100
Cobalt transporter ATP-binding subunit M. agalactiae PG2 29354 6.03 52 1 3%
gi|148377780
MAG_5180
50S ribosomal protein L2 M. agalactiae PG2 30773 10.63 48 3 9%
gi|148377806
MAG_5430
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 48 1 3%
gi|148377362
MAG_0940
Translation initiation factor IF-3 M. agalactiae PG2 23332 9.19 39 2 7% gi|148377738 MAG_4750
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Methionyl-tRNA formyltransferase M. agalactiae PG2 31227 9.21 35 1 2%
gi|148377891
MAG_6280
Alanyl-tRNA synthetase M. agalactiae PG2 100239 5.37 32 1 <1%
gi|148377682
MAG_4160
50S ribosomal protein L3 M. agalactiae PG2 28793 9.75 26 2 7%
gi|148377809
MAG_5460
32 30S ribosomal protein S5 M. agalactiae PG2 25266 10.25 384 17 38%
gi|148377792
MAG_5300
Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 320 13 30%
gi|148377389
MAG_1220
Lipoprotein. MAG_6200 M. agalactiae PG2 26952 9.22 178 3 9%
gi|148377883
MAG_6200
Uridylate kinase M. agalactiae PG2 26309 6.64 136 4 16%
gi|148377314
MAG_0460
Prolipoprotein diacylglyceryl transferase M. agalactiae PG2 37843 9.3 90 1 3%
gi|148377358
MAG_0900
50S ribosomal protein L1 M. agalactiae PG2 24955 9.68 90 3 18%
gi|148377349
MAG_0810
30S ribosomal protein S68 M. agalactiae PG2 12097 10.2 85 1 15%
gi|148377544
MAG_2780
30S ribosomal protein S8 M. agalactiae PG2 24090 9.91 67 2 8%
gi|148377803
MAG_5400
Lipoprotein. MAG_2000 M. agalactiae PG2 26602 8.39 51 1 6%
gi|148377466
MAG_2000
Triosephosphate isomerase M. agalactiae PG2 29382 6.18 50 1 15%
gi|148377776
MAG_5140




component of pyruvate deshydrogenase 
complex
M. agalactiae PG2 26767 7.68 33 1 5%
gi|148377363
MAG_0950
ABC transporter. ATP binding protein M. agalactiae PG2 27496 8.58 31 1 3%
gi|148377430
MAG_1630
Pyruvate dehydrogenase E1 component. 
alphasubunit
M. agalactiae PG2 41321 6.13 28 1 2%
gi|148377361
MAG_0930
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Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 25 1 3%
gi|148377362
MAG_0940
33 30S ribosomal protein S8 M. agalactiae PG2 24090 9.91 452 13 29%
gi|148377803
MAG_5400
30S ribosomal protein S5 M. agalactiae PG2 25266 10.25 147 6 25%
gi|148377792
MAG_5300
P40. lipoprotein M. agalactiae PG2 39951 8.19 132 3 9%
gi|148377507
MAG_2410





M. agalactiae PG2 24126 6.64 88 3 5%
gi|148377898
MAG_6350
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 64 1 3%
gi|148377362
MAG_0940
Lipoprotein. MAG_2000 M. agalactiae PG2 26602 8.29 35 2 6%
gi|148377466
MAG_2000
34 Lipoprotein. MAG_3600 M. agalactiae PG2 21678 9.13 579 14 35%
gi|148377626
MAG_3600





M. agalactiae PG2 28539 9.95 184 8 33%
gi|148377984
MAG_7220
P40. lipoprotein M. agalactiae PG2 39951 8.19 162 2 3%
gi|148377507
MAG_2410
30S ribosomal protein S4 M. agalactiae PG2 22616 10.21 121 14 27%
gi|148377824
MAG_5610
Transcription antitermination protein 
NusG
M. agalactiae PG2 22639 6.22 61 1 7%
gi|148377312
MAG_0440
Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 52 1 7%
gi|148377970
MAG_7080
Hypothetical protein MAG_1220 M. agalactiae PG2 26491 8.69 46 1 3%
gi|148377389
MAG_1220
Pyruvate dehydrogenase E1 component. 
betasubunit
M. agalactiae PG2 36129 5.44 39 1 3%
gi|148377362
MAG_0940
Thymidine kinase M. agalactiae PG2 21731 8.45 29 1 4% gi|148377963 MAG_7010
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Acyl carrier protein phosphodiesterase M. agalactiae PG2 22409 9.32 26 3 5%
gi|148377731
MAG_3680
35 Lipoprotein. MAG_3600 M. agalactiae PG2 21678 9.13 221 9 42%
gi|148377626
MAG_3600
Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 177 5 14%
gi|148377970
MAG_7080
L-lactate dehydrogenase (L-LDH) M. agalactiae PG2 34965 6.13 101 3 9%
gi|148377752
MAG_4900
50S ribosomal protein L6 M. agalactiae PG2 19288 9.88 96 2 5%
gi|148377794
MAG_5320
Acyl carrier protein phosphodiesterase M. agalactiae PG2 22409 9.32 62 2 5%
gi|148377731
MAG_3680
30S ribosomal protein S4 M. agalactiae PG2 22616 10.21 43 3 13%
gi|148377824
MAG_5610
Variable surface lipoprotein A M. agalactiae PG2 24769 8.33 37 2 15%
gi|148377969
MAG_7070
Lipoprotein. MAG_2400 M. agalactiae PG2 38065 8.95 36 2 5%
gi|148377506
MAG_2400
36 Variable surface lipoprotein Y M. agalactiae PG2 37528 8.81 608 14 23%
gi|148377970
MAG_7080
Variable surface lipoprotein A M. agalactiae PG2 24769 8.33 353 6 25%
gi|148377969
MAG_7070
30S ribosomal protein S7 M. agalactiae PG2 17810 10.24 327 12 39%
gi|148377856
MAG_5930
30S ribosomal protein S68 M. agalactiae PG2 12097 10.2 168 3 24%
gi|148377544
MAG_2780
50S ribosomal protein L13 M. agalactiae PG2 16160 10.07 161 4 18%
gi|148377718
MAG_4550
50S ribosomal protein L5 M. agalactiae PG2 20778 9.85 125 8 23%
gi|148377797
MAG_5350
Hypothetical protein MAG_6920 M. agalactiae PG2 20745 5.99 116 2 13%
gi|148377954
MAG_6920
50S ribosomal protein L18 M. agalactiae PG2 12978 10.25 94 3 14%
gi|148377793
MAG_5310
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50S ribosomal protein L10 M. agalactiae PG2 18901 9.26 91 3 17%
gi|148377882
MAG_6190
30S ribosomal protein S9 M. agalactiae PG2 14863 11.42 91 4 20%
gi|148377719
MAG_4560
30S ribosomal protein S60 M. agalactiae PG2 12101 10.24 86 1 13%
gi|148377810
MAG_5470
30S ribosomal protein S69 M. agalactiae PG2 10395 9.94 82 3 8%
gi|148377805
MAG_5420
50S ribosomal protein L17 M. agalactiae PG2 13876 10.53 81 5 25%
gi|148377781
MAG_5190
50S ribosomal protein L32 M. agalactiae PG2 7922 10.31 79 1 21%
gi|148377396
MAG_1290
50S ribosomal protein L11 M. agalactiae PG2 16890 9.37 70 1 8%
gi|148377348
MAG_0800
50S ribosomal protein L23 M. agalactiae PG2 16678 9.63 67 2 12%
gi|148377807
MAG_5440
30S ribosomal protein S63 M. agalactiae PG2 14057 10.49 66 4 28%
gi|148377784
MAG_5220
Lipoprotein. MAG_2400 M. agalactiae PG2 38065 8.95 65 2 5%
gi|148377506
MAG_2400
30S ribosomal protein S62 M. agalactiae PG2 15141 11.09 61 3 8%
gi|148377857
MAG_5940
50S ribosomal protein L14 M. agalactiae PG2 13262 9.88 52 1 8%
gi|148377799
MAG_5370
50S ribosomal protein L27 M. agalactiae PG2 10149 10.91 44 1 9%
gi|148377817
MAG_5540
50S ribosomal protein L22 M. agalactiae PG2 12716 10.88 40 1 6%
gi|148377804
MAG_5410
30S ribosomal protein S6 M. agalactiae PG2 16627 9.87 39 1 5%
gi|148377542
MAG_2760
50S ribosomal protein L6 M. agalactiae PG2 19288 9.88 39 1 5%
gi|148377794
MAG_5320
50S ribosomal protein L15 M. agalactiae PG2 15751 10.81 39 2 11%
gi|148377791
MAG_5290
30S ribosomal protein S61 M. agalactiae PG2 14244 10.35 34 1 7%
gi|148377783
MAG_5210
50S ribosomal protein L24 M. agalactiae PG2 12043 10.3 33 1 7%
gi|148377798
MAG_5360
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50S ribosomal protein L19 M. agalactiae PG2 13446 11.13 33 1 6%
gi|148377890
MAG_6270
Hypothetical protein MAG_3830 M. agalactiae PG2 17288 9.3 32 1 7%
gi|148377649
MAG_3830
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S7: Functional analysis, number of peptide hits, and method of detection of M. agalactiae PG2T liposoluble proteins. The results of 
2D DIGE with the two field strains Nurri and Bortigali are also reported (TPH, total peptide hits; NA, not applicable).
Name Locus Function TPH 2D-PAGE-MS GeLC-MS/MS PG2T Nurri Bortigali
P48, lipoprotein, MAG_0120 MAG_0120 ABC transporter 94 X X X X X
ABC transporter, ATP-binding protein P59, 
MAG_0140 MAG_0140 ABC transporter 40 X NA NA NA
Sugar ABC transporter permease, MAG_0150 MAG_0150 ABC transporter 26 X NA NA NA
Hypothetical protein MAG_0250 MAG_0250
Indigoidine sinthase A 
superfamily, putative 
virulence factor
1 X NA NA NA
HAD superfamily hydrolase, MAG_0270 MAG_0270 Hydrolase 1 X NA NA NA
Hypothetical protein MAG_0280 MAG_0280 ABC transporter 10 X NA NA NA
Oligopeptide ABC transporter, substrate-
bindingprotein (OppA), lipoprotein, MAG_0380 MAG_0380 ABC transporter 1 X NA NA NA
Transcription antitermination protein NusG, 
MAG_0440 MAG_0440 Transcription 1 X NA NA NA
Uridylate kinase, MAG_0460 MAG_0460 Nucleotide metabolism 7 X NA NA NA
Glycerol-3-phosphate dehydrogenase, MAG_0500 MAG_0500 Lipid metabolism 5 X NA NA NA
Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), MAG_0550 MAG_0550 Carbohydrate metabolism 12 X X X X X
Seryl-tRNA synthetase, MAG_0560 MAG_0560 Amino acid metabolism 2 X NA NA NA
Putative inner membrane protein translocase 
component YidC MAG_0590 MAG_0590
Secretion system/Protein 
export 57 X NA NA NA




6 X X NA NA NA
50S ribosomal protein L11, MAG_0800 MAG_0800 Translation 1 X NA NA NA
50S ribosomal protein L1, MAG_0810 MAG_0810 Translation 31 X X X X X
Prolipoprotein diacylglyceryl transferase 
MAG_0900 MAG_0900
Secretion system/Protein 
export 2 X NA NA NA
Pyruvate dehydrogenase E1 component, 
alphasubunit, MAG_0930 MAG_0930 Carbohydrate metabolism 72 X X X X X
Pyruvate dehydrogenase E1 component, 
betasubunit, MAG_0940 MAG_0940 Carbohydrate metabolism 69 X X X X X
Dihydrolipoamide acetyltransferase component of 
pyruvate dehydrogenase complex, MAG_0950 MAG_0950 Carbohydrate metabolism 1 X NA NA NA
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Name Locus Function TPH 2D-PAGE-MS GeLC-MS/MS PG2T Nurri Bortigali
Dihydrolipoamide dehydrogenase (E3 component 




27 X NA NA NA
Hypotetical protein MAG_1000 MAG_1000 ABC transporter 87 X X X X X
Oligopeptide ABC transporter system, 
permeaseprotein (OppC), MAG_1020 MAG_1020 ABC transporter 7 X NA NA NA
Oligopeptide ABC transporter, ATP-
bindingprotein (OppF), MAG_1040 MAG_1040 ABC transporter 11 X NA NA NA
Lipoprotein, MAG_1050 MAG_1050 9 X X NA NA NA
XAA-Pro aminopeptidase, MAG_1180 MAG_1180 Hydrolase 41 X NA NA NA
Prolyl-tRNA synthetase, MAG_1190 MAG_1190 Amino acid metabolism 5 X NA NA NA
Hypothetical membrane protein MAG_1210 MAG_1210 10 X NA NA NA
Hypothetical transmembrane protein MAG_1220 MAG_1220 LemA family 32 X X X X




80 X NA NA NA
Spermidine/putrescine ABC transporter ATP-
binding protein, MAG_1250 MAG_1250 ABC transporter 2 X NA NA NA
50S ribosomal protein L32, MAG_1290 MAG_1290 Translation 1 X NA NA NA





8 X NA NA NA




1 X NA NA NA
Hypothetical protein MAG_1430 MAG_1430 11 X NA NA NA
Pyruvate kinase, MAG_1440 MAG_1440 Carbohydrate metabolism 37 X NA NA NA
Hypothetical lipoprotein MAG_1450 MAG_1450 5 X X NA NA NA




11 X NA NA NA
D-lactate dehydrogenase MAG_1490 MAG_1490 Carbohydrate metabolism 28 X X X X X
Type III restriction-modification system: 
methylase, MAG_1530 MAG_1530
Restriction-modification 
system 9 X NA NA NA
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Name Locus Function TPH 2D-PAGE-MS GeLC-MS/MS PG2T Nurri Bortigali
Trigger factor, MAG_1540 MAG_1540 Protein folding 6 X NA NA NA
ABC transporter, ATP binding protein, 
MAG_1630 MAG_1630 ABC transporter 1 X NA NA NA
Hypothetical lipoprotein MAG_1670 MAG_1670 Mycoides cluster P72 family, putative virulence factor 2 X NA NA NA
Hypothetical protein MAG_1780 MAG_1780 4 X NA NA NA
Hypothetical transmembrane protein MAG_1810 MAG_1810 2 X NA NA NA
Topoisomerase IV subunit B, MAG_1820 MAG_1820 Nucleic acid metabolism 2 X NA NA NA
Hypothetical transmembrane protein MAG_1970 MAG_1970 M. synoviae P80 antigen-like 19 X NA NA NA
Lipoprotein, MAG_1980 MAG_1980 M. synoviae P60 antigen-like 10 X X X X X
Lipoprotein, MAG_2000 MAG_2000 3 X X X X X
Methionyl-tRNA synthetase, MAG_2060 MAG_2060 Amino acid metabolism 3 X NA NA NA
Ribonuclease R, MAG_2080 MAG_2080 Nucleic acid metabolism 1 X NA NA NA
CTP synthetase, MAG_2190 MAG_2190 Nucleotide metabolism 4 X
Isoleucyl-tRNA synthetase , MAG_2200 MAG_2200 Amino acid metabolism 7 X
Hypothetical lipoprotein MAG_2220 MAG_2220 82 X X X X X
Protein-export membrane protein, MAG_2250 MAG_2250 Secretion system/Protein export 13 X NA NA NA
Hypothetical lipoprotein, MAG_2340 MAG_2340 5 X NA NA NA
Lipoprotein, MAG_2350 MAG_2350 4 X X X X X
Hypothetical transmembrane protein MAG_2360 MAG_2360 Hydrolase, DHH superfamily 1 X NA NA NA
Replicative DNA helicase, MAG_2380 MAG_2380 Nucleic acid metabolism 1 X NA NA NA
Lipoprotein, MAG_2400 MAG_2400 4 X X X X X
P40, lipoprotein, MAG_2410 MAG_2410 20 X X X X X
Lipoprotein, MAG_2430 MAG_2430 73 X X X X
DNA recombination protein, MAG_2480 MAG_2480 Nucleic acid metabolism 3 X NA NA NA
30S ribosomal protein S7, MAG_2590 MAG_2590 Translation 17 X NA NA NA
Elongation factor Ts (EF-Ts), MAG_2600 MAG_2600 Translation 17 X NA NA NA
NADH oxidase (NOXASE), MAG_2630 MAG_2630 Energy metabolism 18 X X NA NA NA
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Name Locus Function TPH 2D-PAGE-MS GeLC-MS/MS PG2T Nurri Bortigali
Glycyl-tRNA synthetase, MAG_2670 MAG_2670 Amino acid metabolism 1 X NA NA NA
Hypothetical transmembrane protein MAG_2680 MAG_2680 14 X NA NA NA
Alkylphosphonate ABC transporter substrate-
binding protein, MAG_2690 MAG_2690 ABC transporter 9 X X X X X
Preprotein translocase subunit SecA, MAG_2730 MAG_2730 Secretion system/Protein export 8 X NA NA NA







6 X NA NA NA
30S ribosomal protein S6, MAG_2760 MAG_2760 Translation 1 X NA NA NA





13 X NA NA NA
Hypothetical protein MAG_2810 MAG_2810 3 X NA NA NA
DNA ligase, MAG_2820 MAG_2820 Nucleic acid metabolism 3 X NA NA NA
Putative transmembrane protein, MAG_2920 MAG_2920 1 X NA NA NA
Asparaginyl-tRNA synthetase, MAG_3020 MAG_3020 Amino acid metabolism 2 X NA NA NA
Mg2+ transport protein (MGTE), MAG_3070 MAG_3070 Membrane transport 3 X NA NA NA




2 X NA NA NA
Elongation factor Tu, MAG_3200 MAG_3200 Translation 150 X X NA NA NA
Hypothetical lipoprotein MAG_3240 MAG_3240 2 X NA NA NA
Threonyl-tRNA synthetase, MAG_3440 MAG_3440 Amino acid metabolism 11 X NA NA NA
P30, lipoprotein, MAG_3470 MAG_3470 1 X NA NA NA
ATP synthase B chain, MAG_3520 MAG_3520 Energy metabolism 4 X X X X
F0F1 ATP synthase subunit alpha, MAG_3540 MAG_3540 Energy metabolism 3 X NA NA NA
F0F1 ATP synthase subunit gamma, MAG_3550 MAG_3550 Energy metabolism 1 X NA NA NA
F0F1 ATP synthase subunit beta, MAG_3560 MAG_3560 Energy metabolism 9 X NA NA NA
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Name Locus Function TPH 2D-PAGE-MS GeLC-MS/MS PG2T Nurri Bortigali
Lipoprotein, MAG_3600 MAG_3600 23 X X X X X
Leucyl-tRNA synthetase (leucine-tRNA ligase), 
MAG_3640 MAG_3640 Amino acid metabolism 7 X NA NA NA
Endopeptidase O, MAG_3680 MAG_3680 Hydrolase 26 X NA NA NA
Excinuclease ABC subunit B, MAG_3780 MAG_3780 Nucleic acid metabolism 3 X X NA NA NA
Hypothetical protein MAG_3830 MAG_3830 Hydrolase 1 X NA NA NA
Alanyl-tRNA synthetase, MAG_4160 MAG_4160 Amino acid metabolism 8 X NA NA NA







3 X NA NA NA
Putative glycerol-3-phosphate acyltransferase 
PlsX, MAG_4400 MAG_4400 Lipid metabolism 2 X NA NA NA
Hypothetical protein MAG_4410 MAG_4410 1 X NA NA NA
Hypothetical protein MAG_4440 MAG_4440 Hydrolase, DHH family 5 X NA NA NA
Hypothetical protein MAG_4450 MAG_4450 Hydrolase, DHH family 6 X NA NA NA
Hypothetical protein MAG_4460 MAG_4460 Hydrolase, HAD superfamily 37 X NA NA NA
Glycerol kinase, MAG_4470 MAG_4470 Lipid metabolism 13 X NA NA NA
Hypothetical transmembrane protein MAG_4530 MAG_4530 1 X NA NA NA
50S ribosomal protein L13, MAG_4550 MAG_4550 Translation 4 X NA NA NA
30S ribosomal protein S9, MAG_4560 MAG_4560 Translation 4 X NA NA NA
Cation-transporting P-type ATPase, MAG_4590 MAG_4590 ABC transporter 11 X NA NA NA
ABC transporter, permease protein, MAG_4600 MAG_4600 ABC transporter 3 X NA NA NA
Hypothetical lipoprotein MAG_4720 MAG_4720 ABC transporter 2 X NA NA NA
Lipoprotein MAG_4740 MAG_4740 14 X NA NA NA
Translation initiation factor IF-3, MAG_4750 MAG_4750 Translation 2 X NA NA NA
Malate permease, MAG_4890 MAG_4890 Membrane transport 19 X NA NA NA
L-lactate dehydrogenase (L-LDH), MAG_4900 MAG_4900 Carbohydrate 
metabolism/Amino acid 
61 X X NA NA NA
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2 X NA NA NA
Hexosephosphate transport protein, MAG_4970 MAG_4970 Membrane transport 4 X NA NA NA
P80, lipoprotein, MAG_5030 MAG_5030 ABC transporter 176 X X X X X
Hypothetical protein MAG_5040 MAG_5040 Hydrolase, SNc superfamily 33 X X X X X
ABC transporter ATP-binding protein, 
MAG_5050 MAG_5050 ABC transporter 46 X NA NA NA
ABC transporter permease protein, MAG_5060 MAG_5060 ABC transporter 8 X NA NA NA
ABC transporter permease protein, MAG_5070 MAG_5070 ABC transporter 3 X NA NA NA
Lipoprotein MAG_5080 MAG_5080 34 X X X X X
GTPase ObgE, MAG_5090 MAG_5090 Hydrolase 4 X NA NA NA
Triosephosphate isomerase, MAG_5140 MAG_5140 Carbohydrate metabolism 2 X X NA NA NA
Cobalt transporter ATP-binding subunit, 
MAG_5180 MAG_5180 ABC transporter 2 X NA NA NA
50S ribosomal protein L17, MAG_5190 MAG_5190 Translation 5 X NA NA NA
DNA-directed RNA polymerase subunit alpha, 
MAG_5200 MAG_5200 Transcription 5 X NA NA NA
30S ribosomal protein S61, MAG_5210 MAG_5210 Translation 1 X NA NA NA
30S ribosomal protein S63, MAG_5220 MAG_5220 Translation 4 X NA NA NA
Preprotein translocase subunit SecY, MAG_5260 MAG_5260 Secretion system/Protein export 10 X NA NA NA
50S ribosomal protein L15, MAG_5290 MAG_5290 Translation 2 X NA NA NA
30S ribosomal protein S5, MAG_5300 MAG_5300 Translation 33 X NA NA NA
50S ribosomal protein L18, MAG_5310 MAG_5310 Translation 3 X NA NA NA
50S ribosomal protein L6, MAG_5320 MAG_5320 Translation 3 X NA NA NA
50S ribosomal protein L5, MAG_5350 MAG_5350 Translation 3 X NA NA NA
50S ribosomal protein L24, MAG_5360 MAG_5360 Translation 1 X NA NA NA
50S ribosomal protein L14, MAG_5370 MAG_5370 Translation 1 X NA NA NA
30S ribosomal protein S8, MAG_5400 MAG_5400 Translation 25 X X X X X
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Name Locus Function TPH 2D-PAGE-MS GeLC-MS/MS PG2T Nurri Bortigali
50S ribosomal protein L22, MAG_5410 MAG_5410 Translation 1 X NA NA NA
30S ribosomal protein S69, MAG_5420 MAG_5420 Translation 3 X NA NA NA
50S ribosomal protein L2, MAG_5430 MAG_5430 Translation 29 X NA NA NA
50S ribosomal protein L23, MAG_5440 MAG_5440 Translation 2 X NA NA NA
50S ribosomal protein L4, MAG_5450 MAG_5450 Translation 8 X NA NA NA
50S ribosomal protein L3, MAG_5460 MAG_5460 Translation 22 X X X X X
30S ribosomal protein S60, MAG_5470 MAG_5470 Translation 1 X NA NA NA
50S ribosomal protein L27, MAG_5540 MAG_5540 Translation 1 X NA NA NA
30S ribosomal protein S4, MAG_5610 MAG_5610 Translation 13 X NA NA NA
DNA gyrase subunit A, MAG_5630 MAG_5630 Nucleic acid metabolism 3 X NA NA NA
Modification (methylase) protein of type I 
restriction-modification system, MAG_5650 MAG_5650
Restriction-modification 
system 4 X NA NA NA
Modification (methylase) protein of type I 
restriction-modification system HsdM, 
MAG_5730
MAG_5730 Restriction-modification system 4 X NA NA NA
Glutamyl-tRNA synthetase, MAG_5780 MAG_5780 Amino acid metabolism 11 X NA NA NA
Signal recognition particle protein, MAG_5820 MAG_5820 Secretion system/Protein export 3 X NA NA NA
Phosphoglycerate kinase, MAG_5860 MAG_5860 Carbohydrate metabolism 28 X NA NA NA
5'nucleotidase, MAG_5910 MAG_5910 Hydrolase 53 X X X X X
Elongation factor G, MAG_5920 MAG_5920 Translation 9 X NA NA NA
30S ribosomal protein S7, MAG_5930 MAG_5930 Translation 12 X NA NA NA
30S ribosomal protein S62, MAG_5940 MAG_5940 Translation 3 X NA NA NA
ABC transporter ATP-binding protein, 
MAG_5960 MAG_5960 ABC transporter 27 X NA NA NA
ABC transporter, ATP-binding protein, 
MAG_5990 MAG_5990 ABC transporter 3 X NA NA NA
ABC transporter, ATP-binding protein, 
MAG_6000 MAG_6000 ABC transporter 10 X NA NA NA
DNA-directed RNA polymerase subunit beta', 
MAG_6110 MAG_6110 Nucleic acid metabolism 61 X NA NA NA
DNA-directed RNA polymerase subunit beta, 
MAG_6120 MAG_6120 Nucleic acid metabolism 73 X NA NA NA
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Name Locus Function TPH 2D-PAGE-MS GeLC-MS/MS PG2T Nurri Bortigali
50S ribosomal protein L10, MAG_6190 MAG_6190 Translation 3 X NA NA NA
Lipoprotein, MAG_6200 MAG_6200 Transferase, choline-bindine protein 9 X X X X X
Lysyl-tRNA synthetase, MAG_6210 MAG_6210 Amino acid metabolism 18 X NA NA NA
Hypothetical protein MAG_6230 MAG_6230 Transcription 11 X NA NA NA
ClpB, MAG_6240 MAG_6240 Hydrolase 6 X NA NA NA
50S ribosomal protein L19, MAG_6270 MAG_6270 Translation 1 X NA NA NA
Methionyl-tRNA formyltransferase, MAG_6280 MAG_6280 Amino acid metabolism 2 X NA NA NA
3-keto-L-gulonate-6-phosphate decarboxylase, 
MAG_6350 MAG_6350 Carbohydrate metabolism 3 X NA NA NA





1 X NA NA NA
Hypothetical lipoprotein MAG_6520 MAG_6520 25 X X X X
Hypothetical transmembrane protein MAG_6740 MAG_6740 Secretion system/Protein export 2 X NA NA NA
DNA polymerase III subunit gamma and tau, 
MAG_6870 MAG_6870 Nucleic acid metabolism 2 X NA NA NA
Phosphoglyceromutase, MAG_6890 MAG_6890 Carbohydrate metabolism 3 X NA NA NA
Hypothetical transmembrane protein MAG_6920 MAG_6920 2 X NA NA NA
Thymidine kinase, MAG_7010 MAG_7010 Nucleotide metabolism 1 X NA NA NA
Aminopeptidase (leucine aminopeptidase), 
MAG_7020 MAG_7020
Amino acid metabolism, 
hydrolase 16 X NA NA NA
Variable surface lipoprotein V, MAG_7050 MAG_7050 6 X X X X X
Variable surface lipoprotein W, MAG_7060 MAG_7060 4 X X X X X
Variable surface lipoprotein A, MAG_7070 MAG_7070 11 X X X X X
Variable surface lipoprotein Y, MAG_7080 MAG_7080 74 X X X X
Variable surface lipoprotein U, MAG_7090 MAG_7090 1 X X X X X
Variable surface lipoprotein  D,  MAG_7100 MAG_7100 27 X X X X X
Amidase, MAG_7170 MAG_7170 Amino acid metabolism 1 X NA NA NA
1-acyl-SN-glycerol-3-phosphate acyltransferase, 
MAG_7220 MAG_7220 Lipid metabolism 8 X NA NA NA
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Name Locus Function TPH 2D-PAGE-MS GeLC-MS/MS PG2T Nurri Bortigali
Tyrosyl-tRNA synthetase 1, MAG_7300 MAG_7300 Amino acid metabolism 2 X NA NA NA
Hypothetical transmembrane protein MAG_7360 MAG_7360 2 X NA NA NA
DNA gyrase subunit B, MAG_7370 MAG_7370 Nucleic acid metabolism 3 X NA NA NA
Hypothetical protein MAG_7400 MAG_7400 Transcription 5 X NA NA NA
Cation-transporting P-ATPase, MAG_7420 MAG_7420 Energy metabolism 3 X NA NA NA
ABC transporter ATP-binding protein, 
MAG_7430 MAG_7430 ABC transporter 1 X NA NA NA
ABC transporter permease protein, MAG_7440 MAG_7440 ABC transporter 19 X NA NA NA
Cell division protein ftsH-like protein, MAG_7450 MAG_7450 Cell growth 11 X NA NA NA
Glycerol ABC transporter, ATP-binding protein, 
MCAP_0454 MCAP_0454 ABC transporter 9 X NA NA NA
Hypothetical protein MYPU_3820 MYPU_3820 5 X NA NA NA
Dott.ssa Carla Cacciotto, Characterization of Mycoplasma agalactiae membrane proteome.
Tesi di Dottorato in Scienze Biomolecolari e Biotecnologiche, Università degli Studi di Sassari.
S8: Proteins identified in the  M. agalactiae PG2T proteome potentially resulting from Horizontal Gene Transfer events with  M. 
mycoides subsp. mycoides and M. capricolum subsp. capricolum.
Name Locus
Homolog in M. 
mycoides subsp. 
mycoides








MAG_0380 MSC_0964 MCAP0116 Several homologs from the Hominis group MAG having homolog in the Hominis group
D-lactate dehydrogenase 
MAG_1490 MAG_1490 MSC_0034 MCAP0460
Homolog in M. penetrans also highly 
similar
MAG having homolog in the mycoides cluster and 
other bacteria but not in the Hominis group
Hypothetical protein 
MAG_1670 MAG_1670 MSC_0240 MCAP0033
No homolog outside of the mycoides 
cluster
MAG CDS having no homolog outside of the 
mycoides cluster
Hypothetical protein 
MAG_2220 MAG_2220 MSC_0519 MCAP0451 Several homologs MAG having homolog in the Hominis group
Hypothetical protein 
MAG_2340 MAG_2340 MSC_0519 MCAP0451 Several homologs MAG having homolog in the Hominis group
Lipoprotein, MAG_2430 MAG_2430 MSC_1005 MCAP0268 No homolog outside of the mycoides cluster





MAG_2690 MSC_0790 MCAP0731 Homolog from the Hominis group probably lost MAG having homolog in the Hominis group
Putative transmembrane 
protein, MAG_2920 MAG_2920 MSC_0620 MCAP0357
Homolog from the Hominis group 
probably lost MAG having homolog in the Hominis group
Endopeptidase O, MAG_3680 MAG_3680 MSC_0696 MCAP0466 Homolog in non mollicute bacteria MAG having homolog in the mycoides cluster and other bacteria but not in the Hominis group
Glycerol kinase, MAG_4470 MAG_4470 MSC_0258 MCAP0218 Homolog from the Hominis group probably lost MAG having homolog in the Hominis group
ABC transporter, permease 
protein, MAG_4600 MAG_4600 MSC_0324 MCAP0798 No paralog MAG having homolog in the Hominis group
Malate permease, MAG_4890 MAG_4890 MSC_0035 MCAP0780 Homolog in M. penetrans MAG having homolog in the mycoides cluster and other bacteria but not in the Hominis group
Hexosephosphate transport 
protein, MAG_4970 MAG_4970 MSC_0118 MCAP0814
Homolog from the Hominis group 
probably lost MAG having homolog in the Hominis group
Hypothetical protein 
MAG_6520 MAG_6520 MSC_0519 MCAP0451 Several homologs MAG having homolog in the Hominis group
Glycerol ABC transporter, 
ATP-binding protein, 
MCAP_0454
MAG_2310 MSC_0516 Several homologs MAG having homolog in the Hominis group
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S9: Proteins identified in the M. agalactiae PG2Tproteome potentially resulting from Horizontal Gene Transfer events with other 
bacteria.
Name Locus Putative HGT with organisms of Comments
Hypothetical protein MAG_0250 MAG_0250 Firmicutes/Proteobacteria No paralog, no homolog in Mollicutes
Putative phosphoketolase, MAG_1230 MAG_1230 Firmicutes (Lactobacillales) No paralog, no homolog in Mollicutes
Alcohol dehydrogenase, MAG_2740 MAG_2740 Firmicutes/Proteobacteria
Paralog MAG_4280, MAG_4340 (also HGT 
acquired), no homolog in the Hominis group
Alcohol dehydrogenase, MAG_4340 MAG_4340 Firmicutes/Proteobacteria
Paralog MAG_4280, MAG_2740 (also HGT 
acquired), no homolog in the Hominis group
Hypothetical protein MAG_4460 MAG_4460 Pneumoniae group
No homolog in the Hominis group, homolog 
only in U. urealyticum
Modification (methylase) protein of type irestriction-
modification system, MAG_5650
MAG_5650 Firmicutes
Paralog MAG_5730 (also HGT acquired), 
paralog from the Hominis group probably lost
Modification (methylase) protein of type irestriction-
modification system HsdM, MAG_5730
MAG_5730 Firmicutes
Paralog MAG_5730 (also HGT acquired), 
paralog from the Hominis group probably lost
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